0001752724-21-069919.txt : 20210401 0001752724-21-069919.hdr.sgml : 20210401 20210401162101 ACCESSION NUMBER: 0001752724-21-069919 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210131 FILED AS OF DATE: 20210401 PERIOD START: 20211031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALGER FUNDS CENTRAL INDEX KEY: 0000003521 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-01355 FILM NUMBER: 21798367 BUSINESS ADDRESS: STREET 1: 360 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 212-806-8833 MAIL ADDRESS: STREET 1: 360 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: ALGER FUND DATE OF NAME CHANGE: 19920703 0000003521 S000009164 Alger Health Sciences Fund C000024915 Alger Health Sciences Fund Class A AHSAX C000024917 Alger Health Sciences Fund Class C AHSCX C000156505 Alger Health Sciences Fund Class Z AHSZX NPORT-P 1 primary_doc.xml NPORT-P false 0000003521 XXXXXXXX S000009164 C000024917 C000024915 C000156505 Alger Funds 811-01355 0000003521 549300GSR7CWA7IW4H72 360 Park Avenue South NULL New York 10010 212-806-8833 Alger Health Sciences Fund S000009164 549300YENKK0UM5YXK80 2021-10-31 2021-01-31 N 325442651.55 9465265.73 315977385.82 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 4418586.85000000 N ABIOMED INC 5493001EZN4ZTB4Z5887 ABIOMED INC 0.00000000 003654100 10957.00000000 NS USD 3815775.25000000 1.207610234541 Long EC CORP US N 1 N N N THERMO FISHER SCIENTIFIC INC HCHV7422L5HDJZCRFL38 THERMO FISHER SCIENTIFIC INC 0.00000000 883556102 6272.00000000 NS USD 3196838.40000000 1.011730124832 Long EC CORP US N 1 N N N KADMON HOLDINGS INC 549300BBVICD23L50606 KADMON HOLDINGS INC 0.00000000 48283N106 177220.00000000 NS USD 850656.00000000 0.269214202716 Long EC CORP US N 1 N N N PROGYNY INC N/A PROGYNY INC 0.00000000 74340E103 70197.00000000 NS USD 3283113.69000000 1.039034385793 Long EC CORP US N 1 N N N HALOZYME THERAPEUTICS INC 529900242I3SV9AGM753 HALOZYME THERAPEUTICS INC 0.00000000 40637H109 69352.00000000 NS USD 3300461.68000000 1.044524648950 Long EC CORP US N 1 N N N SAGE THERAPEUTICS INC 5493000JX4BJS9W6CN35 SAGE THERAPEUTICS INC 0.00000000 78667J108 21814.00000000 NS USD 1759299.10000000 0.556780066850 Long EC CORP US N 1 N N N ABBVIE INC FR5LCKFTG8054YNNRU85 ABBVIE INC 0.00000000 00287Y109 86955.00000000 NS USD 8911148.40000000 2.820185494248 Long EC CORP US N 1 N N N TCR2 THERAPEUTICS INC 5493007TR1ORJAZ8YK34 TCR2 THERAPEUTICS INC 0.00000000 87808K106 92742.00000000 NS USD 2386251.66000000 0.755196975190 Long EC CORP US N 1 N N N REATA PHARMACEUTICALS INC-A 5299005F094GH9QDDD80 REATA PHARMACEUTICALS INC-A 0.00000000 75615P103 7912.00000000 NS USD 819604.08000000 0.259386942477 Long EC CORP US N 1 N N N TG THERAPEUTICS INC 529900X21UKABN9NJ529 TG THERAPEUTICS INC 0.00000000 88322Q108 75303.00000000 NS USD 3634875.81000000 1.150359479228 Long EC CORP US N 1 N N N PHREESIA INC 5493000HHF8NU4QOCG53 PHREESIA INC 0.00000000 71944F106 16070.00000000 NS USD 1049210.30000000 0.332052338896 Long EC CORP US N 1 N N N CIGNA CORP 549300VIWYMSIGT1U456 CIGNA CORP 0.00000000 125523100 9637.00000000 NS USD 2091710.85000000 0.661981187220 Long EC CORP US N 1 N N N ROCKET PHARMACEUTICALS INC 549300R7VV82YUIN4Y93 ROCKET PHARMACEUTICALS INC 0.00000000 77313F106 12495.00000000 NS USD 688224.60000000 0.217808182131 Long EC CORP US N 1 N N N ARROWHEAD PHARMACEUTICALS IN 549300O3CSB8T7OZ3D66 ARROWHEAD PHARMACEUTICALS IN 0.00000000 04280A100 34809.00000000 NS USD 2686210.53000000 0.850127461821 Long EC CORP US N 1 N N N ADAPTIVE BIOTECHNOLOGIES 549300ZTF7OT1FW66Q96 ADAPTIVE BIOTECHNOLOGIES 0.00000000 00650F109 26105.00000000 NS USD 1448044.35000000 0.458274678816 Long EC CORP US N 1 N N N ARVINAS INC N/A ARVINAS INC 0.00000000 04335A105 9854.00000000 NS USD 743385.76000000 0.235265494734 Long EC CORP US N 1 N N N STAAR SURGICAL CO 5299006LRHI7OJ8BY308 STAAR SURGICAL CO 0.00000000 852312305 31306.00000000 NS USD 3211369.48000000 1.016328896976 Long EC CORP US N 1 N N N TABULA RASA HEALTHCARE INC 549300K6KY242XRMEF28 TABULA RASA HEALTHCARE INC 0.00000000 873379101 46387.00000000 NS USD 2634317.73000000 0.833704514379 Long EC CORP US N 1 N N N EHEALTH INC 5299003O8Y5OKXUZQ421 EHEALTH INC 0.00000000 28238P109 22366.00000000 NS USD 1070213.10000000 0.338699270272 Long EC CORP US N 1 N N N BIOMARIN PHARMACEUTICAL INC NSLL8ITTRR0J5HEMR848 BIOMARIN PHARMACEUTICAL INC 0.00000000 09061G101 38951.00000000 NS USD 3224363.78000000 1.020441311530 Long EC CORP US N 1 N N N ILLUMINA INC SQ95QG8SR5Q56LSNF682 ILLUMINA INC 0.00000000 452327109 6785.00000000 NS USD 2893395.40000000 0.915696986507 Long EC CORP US N 1 N N N BIOGEN INC W8J5WZB5IY3K0NDQT671 BIOGEN INC 0.00000000 09062X103 17725.00000000 NS USD 5009262.25000000 1.585323024621 Long EC CORP US N 1 N N N BERKELEY LIGHTS INC 549300LTLRE4N65CD358 BERKELEY LIGHTS INC 0.00000000 084310101 11150.00000000 NS USD 802800.00000000 0.254068815056 Long EC CORP US N 1 N N N NEOGENOMICS INC N/A NEOGENOMICS INC 0.00000000 64049M209 29633.00000000 NS USD 1571141.66000000 0.497232311712 Long EC CORP US N 1 N N N PROSETTA BIOSCIENCES INC. /PFD N/A PROSETTA BIOSCIENCES INC. SERIES D PREFERRED 0.00000000 N/A 897366.00000000 NS USD 134604.90000000 0.042599535929 Long EP CORP US Y 3 N N N 10X GENOMICS INC-CLASS A 5493003Z6741WNLG7H43 10X GENOMICS INC-CLASS A 0.00000000 88025U109 26554.00000000 NS USD 4544717.10000000 1.438304544550 Long EC CORP US N 1 N N N ARGENX SE - ADR 7245009C5FZE6G9ODQ71 ARGENX SE - ADR 0.00000000 04016X101 5887.00000000 NS USD 1725008.74000000 0.545927910481 Long EC CORP NL N 1 N N N ACADIA PHARMACEUTICALS INC 529900O3044NO0PEA039 ACADIA PHARMACEUTICALS INC 0.00000000 004225108 25375.00000000 NS USD 1219268.75000000 0.385872155640 Long EC CORP US N 1 N N N CATALENT INC N/A CATALENT INC 0.00000000 148806102 28822.00000000 NS USD 3315971.10000000 1.049433044518 Long EC CORP US N 1 N N N SCHOLAR ROCK HOLDING CORP 549300Z1FLPGL4OWJ459 SCHOLAR ROCK HOLDING CORP 0.00000000 80706P103 29820.00000000 NS USD 1779061.20000000 0.563034343544 Long EC CORP US N 1 N N N HORIZON THERAPEUTICS PLC 529900P0GSQ79OOZEV53 HORIZON THERAPEUTICS PLC 0.00000000 G46188101 29529.00000000 NS USD 2140261.92000000 0.677346549483 Long EC CORP US N 1 N N N FATE THERAPEUTICS INC 549300L14Q4UHOODLA90 FATE THERAPEUTICS INC 0.00000000 31189P102 11277.00000000 NS USD 1022034.51000000 0.323451789863 Long EC CORP US N 1 N N N TELADOC HEALTH INC 549300I2PVFBC9MFAC61 TELADOC HEALTH INC 0.00000000 87918A105 23767.00000000 NS USD 6270447.61000000 1.984460879606 Long EC CORP US N 1 N N N SEAGEN INC N/A SEAGEN INC 0.00000000 81181C104 13296.00000000 NS USD 2184133.92000000 0.691231087418 Long EC CORP US N 1 N N N INCYTE CORP 549300Z4WN6JVZ3T4680 INCYTE CORP 0.00000000 45337C102 17359.00000000 NS USD 1557970.25000000 0.493063845678 Long EC CORP US N 1 N N N CRYOPORT INC N/A CRYOPORT INC 0.00000000 229050307 60956.00000000 NS USD 4157199.20000000 1.315663521049 Long EC CORP US N 1 N N N ASTRAZENECA PLC-SPONS ADR PY6ZZQWO2IZFZC3IOL08 ASTRAZENECA PLC-SPONS ADR 0.00000000 046353108 21987.00000000 NS USD 1112542.20000000 0.352095513770 Long EC CORP GB N 1 N N N BOSTON SCIENTIFIC CORP Y6ZDD9FP4P8JSSJMW954 BOSTON SCIENTIFIC CORP 0.00000000 101137107 55636.00000000 NS USD 1971739.84000000 0.624012960574 Long EC CORP US N 1 N N N ELI LILLY & CO FRDRIPF3EKNDJ2CQJL29 ELI LILLY & CO 0.00000000 532457108 56745.00000000 NS USD 11801257.65000000 3.734842485443 Long EC CORP US N 1 N N N 1LIFE HEALTHCARE INC N/A 1LIFE HEALTHCARE INC 0.00000000 68269G107 67121.00000000 NS USD 3396322.60000000 1.074862554225 Long EC CORP US N 1 N N N ABBOTT LABORATORIES HQD377W2YR662HK5JX27 ABBOTT LABORATORIES 0.00000000 002824100 56232.00000000 NS USD 6949712.88000000 2.199433627809 Long EC CORP US N 1 N N N FORTE BIOSCIENCES INC 529900Z84WFDHPS3JP76 FORTE BIOSCIENCES INC 0.00000000 34962G109 218204.00000000 NS USD 7388387.44000000 2.338264626383 Long EC CORP US N 1 N N N TANDEM DIABETES CARE INC 549300JEPFOD0K4D3I05 TANDEM DIABETES CARE INC 0.00000000 875372203 16965.00000000 NS USD 1571807.25000000 0.497442956533 Long EC CORP US N 1 N N N INTUITIVE SURGICAL INC 54930052SRG011710797 INTUITIVE SURGICAL INC 0.00000000 46120E602 5781.00000000 NS USD 4322106.84000000 1.367853217971 Long EC CORP US N 1 N N N DEXCOM INC 549300YSK3QDSFR5EU59 DEXCOM INC 0.00000000 252131107 23486.00000000 NS USD 8803727.10000000 2.786188979047 Long EC CORP US N 1 N N N TURNING POINT THERAPEUTICS I N/A TURNING POINT THERAPEUTICS I 0.00000000 90041T108 23907.00000000 NS USD 3000089.43000000 0.949463336502 Long EC CORP US N 1 N N N ZOETIS INC 549300HD9Q1LOC9KLJ48 ZOETIS INC 0.00000000 98978V103 28532.00000000 NS USD 4401061.00000000 1.392840499828 Long EC CORP US N 1 N N N IOVANCE BIOTHERAPEUTICS INC 549300220Z2GHH33XL82 IOVANCE BIOTHERAPEUTICS INC 0.00000000 462260100 18549.00000000 NS USD 813188.16000000 0.257356442737 Long EC CORP US N 1 N N N ROYALTY PHARMA PLC- CL A 549300FGFN7VOK8BZR03 ROYALTY PHARMA PLC- CL A 0.00000000 G7709Q104 28300.00000000 NS USD 1330383.00000000 0.421037409543 Long EC CORP US N 1 N N N WEST PHARMACEUTICAL SERVICES 5493007NKRGM1RJQ1P16 WEST PHARMACEUTICAL SERVICES 0.00000000 955306105 9553.00000000 NS USD 2861027.97000000 0.905453395842 Long EC CORP US N 1 N N N EDWARDS LIFESCIENCES CORP YA13X31F3V31L8TMPR58 EDWARDS LIFESCIENCES CORP 0.00000000 28176E108 41292.00000000 NS USD 3409893.36000000 1.079157405885 Long EC CORP US N 1 N N N BEIGENE LTD-ADR 549300JFUK6FRD5MH739 BEIGENE LTD-ADR 0.00000000 07725L102 4231.00000000 NS USD 1353920.00000000 0.428486360340 Long EC CORP CN N 1 N N N IRHYTHM TECHNOLOGIES INC 549300FJI72RJGDQS384 IRHYTHM TECHNOLOGIES INC 0.00000000 450056106 8463.00000000 NS USD 1425338.46000000 0.451088756336 Long EC CORP US N 1 N N N VERTEX PHARMACEUTICALS INC 54930015RAQRRZ5ZGJ91 VERTEX PHARMACEUTICALS INC 0.00000000 92532F100 12804.00000000 NS USD 2933140.32000000 0.928275392996 Long EC CORP US N 1 N N N DANAHER CORP S4BKK9OTCEWQ3YHPFM11 DANAHER CORP 0.00000000 235851102 37243.00000000 NS USD 8857875.12000000 2.803325654781 Long EC CORP US N 1 N N N NEVRO CORP 254900SH91I4BOYKUE38 NEVRO CORP 0.00000000 64157F103 28731.00000000 NS USD 4648388.49000000 1.471114294441 Long EC CORP US N 1 N N N BENEFITFOCUS INC 254900W89KP1OS3RXO89 BENEFITFOCUS INC 0.00000000 08180D106 245565.00000000 NS USD 3020449.50000000 0.955906857752 Long EC CORP US N 1 N N N NATERA INC N/A NATERA INC 0.00000000 632307104 69701.00000000 NS USD 7432914.64000000 2.352356520929 Long EC CORP US N 1 N N N BIOHAVEN PHARMACEUTICAL HOLD 5299007STZTNN32O9920 BIOHAVEN PHARMACEUTICAL HOLD 0.00000000 G11196105 8756.00000000 NS USD 746186.32000000 0.236151811327 Long EC CORP US N 1 N N N SARTORIUS AG-VORZUG /EUR/ 529900EQV2DY4FOAMU38 SARTORIUS AG-VORZUG /EUR/ 0.00000000 D6705R119 9983.00000000 NS 4962101.64000000 1.570397712837 Long EC CORP DE N 2 N N N QUANTERIX CORP N/A QUANTERIX CORP 0.00000000 74766Q101 25300.00000000 NS USD 1637922.00000000 0.518366843168 Long EC CORP US N 1 N N N EXACT SCIENCES CORP 549300VM3X1FYD4N9Z14 EXACT SCIENCES CORP 0.00000000 30063P105 31927.00000000 NS USD 4379107.32000000 1.385892635523 Long EC CORP US N 1 N N N DENALI THERAPEUTICS INC 549300ZTQ2HO18L3Q830 DENALI THERAPEUTICS INC 0.00000000 24823R105 16634.00000000 NS USD 1139429.00000000 0.360604603726 Long EC CORP US N 1 N N N APELLIS PHARMACEUTICALS INC 254900HS0ZFRXXSB9D42 APELLIS PHARMACEUTICALS INC 0.00000000 03753U106 14596.00000000 NS USD 646164.92000000 0.204497204229 Long EC CORP US N 1 N N N IDEXX LABORATORIES INC OGMTXK0LUU1HKV2P0J84 IDEXX LABORATORIES INC 0.00000000 45168D104 19183.00000000 NS USD 9182518.44000000 2.906068235285 Long EC CORP US N 1 N N N INTELLIA THERAPEUTICS INC 5493002T5BCPE5DZC723 INTELLIA THERAPEUTICS INC 0.00000000 45826J105 20873.00000000 NS USD 1307067.26000000 0.413658482744 Long EC CORP US N 1 N N N MIRATI THERAPEUTICS INC 529900GYRW59IDQV6N54 MIRATI THERAPEUTICS INC 0.00000000 60468T105 7667.00000000 NS USD 1574265.11000000 0.498220815997 Long EC CORP US N 1 N N N PERSONALIS INC N/A PERSONALIS INC 0.00000000 71535D106 137419.00000000 NS USD 5286508.93000000 1.673065594957 Long EC CORP US N 1 N N N VEEVA SYSTEMS INC-CLASS A 549300YZEXPDB92M2F02 VEEVA SYSTEMS INC-CLASS A 0.00000000 922475108 27719.00000000 NS USD 7662640.36000000 2.425059736510 Long EC CORP US N 1 N N N GUARDANT HEALTH INC 254900M8C3E5VC8BR186 GUARDANT HEALTH INC 0.00000000 40131M109 53316.00000000 NS USD 8290638.00000000 2.623807390039 Long EC CORP US N 1 N N N VIATRIS INC 254900ZZTSW7NL773X71 VIATRIS INC 0.00000000 92556V106 123800.00000000 NS USD 2103362.00000000 0.665668523885 Long EC CORP US N 1 N N N KARUNA THERAPEUTICS INC N/A KARUNA THERAPEUTICS INC 0.00000000 48576A100 14251.00000000 NS USD 1414126.73000000 0.447540486585 Long EC CORP US N 1 N N N BIO-TECHNE CORP 54930073RLKQ51TILZ35 BIO-TECHNE CORP 0.00000000 09073M104 24100.00000000 NS USD 7830331.00000000 2.478130192665 Long EC CORP US N 1 N N N OCULAR THERAPEUTIX INC 529900ABAWFXOHSIHG03 OCULAR THERAPEUTIX INC 0.00000000 67576A100 70477.00000000 NS USD 1279157.55000000 0.404825663925 Long EC CORP US N 1 N N N HUMANA INC 529900YLDW34GJAO4J06 HUMANA INC 0.00000000 444859102 13306.00000000 NS USD 5097661.66000000 1.613299523562 Long EC CORP US N 1 N N N UNITEDHEALTH GROUP INC 549300GHBMY8T5GXDE41 UNITEDHEALTH GROUP INC 0.00000000 91324P102 56734.00000000 NS USD 18925327.72000000 5.989456388116 Long EC CORP US N 1 N N N INVITAE CORP 549300MYI59DZW1WIX92 INVITAE CORP 0.00000000 46185L103 95423.00000000 NS USD 4725346.96000000 1.495469983630 Long EC CORP US N 1 N N N FORTE BIOSCIEN WT EX 02/20/21 N/A FORTE BIOSCIENCES WARRANTS EXP 02/20/21 0.00000000 N/A 211625.00000000 NS USD 4930016.00000000 1.560243302604 N/A DE CORP US Y 2 N/A N/A Call Purchased FORTE BIOSCIENCES FORTE BIOSCIENCES 211625.00000000 USD 0.00000000 USD 2021-02-20 XXXX 4930016.00000000 N N N REPLIGEN CORP 54930006QJ0T5AUO1E71 REPLIGEN CORP 0.00000000 759916109 27038.00000000 NS USD 5407600.00000000 1.711388296338 Long EC CORP US N 1 N N N AURINIA PHARMACEUTICALS INC 5299008YP2BW4570ML28 AURINIA PHARMACEUTICALS INC 0.00000000 05156V102 222048.00000000 NS USD 3710422.08000000 1.174268237700 Long EC CORP CA N 1 N N N INSULET CORP 549300TZTYD2PYN92D43 INSULET CORP 0.00000000 45784P101 29716.00000000 NS USD 7939520.88000000 2.512686425136 Long EC CORP US N 1 N N N JOHNSON & JOHNSON 549300G0CFPGEF6X2043 JOHNSON & JOHNSON 0.00000000 478160104 39964.00000000 NS USD 6519327.32000000 2.063225918235 Long EC CORP US N 1 N N N TOLERO DCR N/A TOLERO DCR 0.00000000 N/A 1956996.00000000 NS USD 1350327.24000000 0.427349329603 Long EC CORP US Y 3 N N N SCHRODINGER INC N/A SCHRODINGER INC 0.00000000 80810D103 22953.00000000 NS USD 2073344.49000000 0.656168632011 Long EC CORP US N 1 N N N CHEMOCENTRYX INC 529900YTTXUSFQTAKY40 CHEMOCENTRYX INC 0.00000000 16383L106 22898.00000000 NS USD 1305414.98000000 0.413135571905 Long EC CORP US N 1 N N N MASIMO CORP 549300Q4A8JK0PIYCU29 MASIMO CORP 0.00000000 574795100 17282.00000000 NS USD 4422809.44000000 1.399723410117 Long EC CORP US N 1 N N N QUIDEL CORP 549300X2FQ6S98OQLQ46 QUIDEL CORP 0.00000000 74838J101 19613.00000000 NS USD 4922274.61000000 1.557793320311 Long EC CORP US N 1 N N N 2021-03-02 Alger Funds Anthony Caputo Anthony Caputo Assistant Treasurer XXXX NPORT-EX 2 brhc_algerfundsi.htm POI


THE ALGER FUNDS

QUARTERLY REPORT
JANUARY 31, 2021





THE ALGER FUNDS

 

 ALGER CAPITAL APPRECIATION FUND



Schedule of Investments January 31, 2021 (Unaudited)
 
COMMON STOCKS—98.4%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—1.2%
           
Raytheon Technologies Corp.
   
68,055
   
$
4,541,310
 
TransDigm Group, Inc.*
   
53,958
     
29,853,882
 
             
34,395,192
 
AIR FREIGHT & LOGISTICS—0.5%
               
XPO Logistics, Inc.*
   
127,667
     
14,095,714
 
APPAREL ACCESSORIES & LUXURY GOODS—1.0%
               
LVMH Moet Hennessy Louis Vuitton SE
   
50,909
     
30,776,816
 
APPAREL RETAIL—0.2%
               
The TJX Cos., Inc.
   
90,419
     
5,790,433
 
APPLICATION SOFTWARE—9.5%
               
Adobe, Inc.*
   
221,902
     
101,801,981
 
Autodesk, Inc.*
   
14,929
     
4,141,752
 
Cadence Design Systems, Inc.*
   
42,928
     
5,597,382
 
Datadog, Inc., Cl. A*
   
63,656
     
6,540,654
 
DocuSign, Inc., Cl. A*
   
6,665
     
1,552,212
 
Five9, Inc.*
   
45,106
     
7,498,873
 
Intuit, Inc.
   
90,275
     
32,610,038
 
Palantir Technologies, Inc., Cl. A*,@,(a)
   
687,886
     
20,709,014
 
RingCentral, Inc., Cl. A*
   
71,625
     
26,710,395
 
salesforce.com, Inc.*
   
341,894
     
77,117,611
 
             
284,279,912
 
AUTOMOBILE MANUFACTURERS—1.7%
               
Tesla, Inc.*
   
65,188
     
51,728,634
 
AUTOMOTIVE RETAIL—0.7%
               
Carvana Co., Cl. A*
   
33,120
     
8,650,613
 
Lithia Motors, Inc., Cl. A
   
39,085
     
12,455,608
 
             
21,106,221
 
BIOTECHNOLOGY—1.3%
               
AbbVie, Inc.
   
145,918
     
14,953,677
 
Genmab AS#,*
   
242,874
     
9,637,240
 
Vertex Pharmaceuticals, Inc.*
   
58,190
     
13,330,165
 
             
37,921,082
 
CASINOS & GAMING—1.3%
               
DraftKings, Inc., Cl. A*
   
497,496
     
26,919,508
 
Las Vegas Sands Corp.
   
251,853
     
12,111,611
 
             
39,031,119
 
CONSTRUCTION MACHINERY & HEAVY TRUCKS—0.3%
 
PACCAR, Inc.
   
84,749
     
7,730,804
 
DATA PROCESSING & OUTSOURCED SERVICES—8.8%
 
Fidelity National Information Services, Inc.
   
26,223
     
3,237,492
 
Fiserv, Inc.*
   
497,925
     
51,131,918
 
PayPal Holdings, Inc.*
   
358,920
     
84,098,545
 
Square, Inc., Cl. A*
   
8,260
     
1,783,830
 
Visa, Inc., Cl. A
   
634,212
     
122,561,469
 
             
262,813,254
 

- 2 -

THE ALGER FUNDS
 
ALGER CAPITAL APPRECIATION FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)
 
COMMON STOCKS—98.4% (CONT.)
 
SHARES
   
VALUE
 
DIVERSIFIED BANKS—0.2%
           
Bank of America Corp.
   
106,794
   
$
3,166,442
 
JPMorgan Chase & Co.
   
19,421
     
2,498,900
 
             
5,665,342
 
DIVERSIFIED SUPPORT SERVICES—0.6%
               
Cintas Corp.
   
45,336
     
14,422,288
 
Copart, Inc.*
   
24,582
     
2,697,875
 
             
17,120,163
 
ELECTRICAL COMPONENTS & EQUIPMENT—0.3%
               
AMETEK, Inc.
   
83,651
     
9,474,312
 
FINANCIAL EXCHANGES & DATA—1.6%
               
CME Group, Inc., Cl. A
   
137,966
     
25,073,941
 
S&P Global, Inc.
   
70,243
     
22,267,031
 
             
47,340,972
 
FOOD DISTRIBUTORS—0.8%
               
Sysco Corp.
   
347,316
     
24,836,567
 
FOOTWEAR—1.7%
               
NIKE, Inc., Cl. B
   
390,796
     
52,206,438
 
GENERAL MERCHANDISE STORES—0.2%
               
Target Corp.
   
31,482
     
5,703,594
 
HEALTHCARE EQUIPMENT—4.9%
               
Boston Scientific Corp.*
   
60,213
     
2,133,949
 
Danaher Corp.
   
393,956
     
93,698,495
 
DexCom, Inc.*
   
27,354
     
10,253,647
 
Intuitive Surgical, Inc.*
   
21,704
     
16,226,778
 
Medtronic PLC
   
209,734
     
23,349,686
 
             
145,662,555
 
HEALTHCARE SERVICES—0.7%
               
Cigna Corp.
   
20,794
     
4,513,338
 
Guardant Health, Inc.*
   
110,535
     
17,188,192
 
             
21,701,530
 
HEALTHCARE SUPPLIES—0.6%
               
Align Technology, Inc.*
   
32,835
     
17,250,852
 
HOME IMPROVEMENT RETAIL—0.9%
               
Lowe's Cos., Inc.
   
162,929
     
27,184,704
 
INDUSTRIAL CONGLOMERATES—0.2%
               
General Electric Co.
   
488,190
     
5,213,869
 
INDUSTRIAL GASES—0.4%
               
Air Products & Chemicals, Inc.
   
44,493
     
11,868,953
 
INTERACTIVE MEDIA & SERVICES—8.5%
               
Alphabet, Inc., Cl. C*
   
62,465
     
114,669,499
 
Facebook, Inc., Cl. A*
   
376,568
     
97,278,811
 
Pinterest, Inc., Cl. A*
   
549,481
     
37,644,943
 
Snap, Inc., Cl. A*
   
75,757
     
4,010,576
 
             
253,603,829
 

- 3 -

THE ALGER FUNDS
 
ALGER CAPITAL APPRECIATION FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)
 
COMMON STOCKS—98.4% (CONT.)
 
SHARES
   
VALUE
 
INTERNET & DIRECT MARKETING RETAIL—11.4%
           
Alibaba Group Holding Ltd.#,*
   
129,334
   
$
32,828,849
 
Altaba, Inc.*,@,(b)
   
259,825
     
3,616,764
 
Amazon.com, Inc.*
   
81,518
     
261,363,012
 
Booking Holdings, Inc.*
   
9,522
     
18,513,910
 
MercadoLibre, Inc.*
   
14,056
     
25,012,793
 
             
341,335,328
 
INTERNET SERVICES & INFRASTRUCTURE—1.6%
               
Shopify, Inc., Cl. A*
   
15,003
     
16,482,146
 
Twilio, Inc., Cl. A*
   
83,212
     
29,908,889
 
             
46,391,035
 
INVESTMENT BANKING & BROKERAGE—0.8%
               
Morgan Stanley
   
350,589
     
23,506,993
 
LEISURE FACILITIES—0.2%
               
Vail Resorts, Inc.
   
18,838
     
5,010,155
 
MANAGED HEALTHCARE—0.5%
               
UnitedHealth Group, Inc.
   
43,597
     
14,543,087
 
MOVIES & ENTERTAINMENT—1.3%
               
Live Nation Entertainment, Inc.*
   
145,913
     
9,695,919
 
Netflix, Inc.*
   
44,113
     
23,485,320
 
The Walt Disney Co.*
   
41,978
     
7,059,440
 
             
40,240,679
 
PHARMACEUTICALS—0.2%
               
Horizon Therapeutics PLC*
   
90,187
     
6,536,754
 
RAILROADS—1.0%
               
Union Pacific Corp.
   
147,211
     
29,069,756
 
RESEARCH & CONSULTING SERVICES—0.5%
               
CoStar Group, Inc.*
   
18,065
     
16,253,261
 
RESTAURANTS—1.6%
               
Chipotle Mexican Grill, Inc., Cl. A*
   
14,868
     
22,004,640
 
Starbucks Corp.
   
264,020
     
25,559,776
 
             
47,564,416
 
SEMICONDUCTOR EQUIPMENT—1.1%
               
Lam Research Corp.
   
69,693
     
33,727,927
 
SEMICONDUCTORS—9.8%
               
Advanced Micro Devices, Inc.*
   
491,415
     
42,084,780
 
Microchip Technology, Inc.
   
70,789
     
9,635,091
 
Micron Technology, Inc.*
   
369,732
     
28,938,924
 
NVIDIA Corp.
   
83,361
     
43,313,542
 
NXP Semiconductors NV
   
256,938
     
41,230,841
 
QUALCOMM, Inc.
   
511,439
     
79,927,687
 
Taiwan Semiconductor Manufacturing Co., Ltd.#
   
383,630
     
46,618,717
 
             
291,749,582
 
SPECIALTY CHEMICALS—1.1%
               
The Sherwin-Williams Co.
   
47,293
     
32,717,297
 

- 4 -

THE ALGER FUNDS
 
ALGER CAPITAL APPRECIATION FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—98.4% (CONT.)
 
SHARES
   
VALUE
 
SYSTEMS SOFTWARE—8.9%
Microsoft Corp.
   
1,089,134
   
$
252,635,523
 
ServiceNow, Inc.*
   
25,321
     
13,753,354
 
             
266,388,877
 
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—7.2%
Apple, Inc.
   
1,639,293
     
216,321,104
 
TRUCKING—0.7%
Uber Technologies, Inc.*
   
387,411
     
19,730,842
 
WIRELESS TELECOMMUNICATION SERVICES—2.4%
T-Mobile US, Inc.*
   
560,816
     
70,707,681
 
TOTAL COMMON STOCKS
(Cost $1,524,185,796)
           
2,936,297,635
 
REAL ESTATE INVESTMENT TRUST—0.2%
 
SHARES
   
VALUE
 
RETAIL—0.2%
Simon Property Group, Inc.
   
70,628
     
6,563,460
 
(Cost $6,395,198)
           
6,563,460
 
SPECIAL PURPOSE VEHICLE—0.1%
 
SHARES
   
VALUE
 
DATA PROCESSING & OUTSOURCED SERVICES—0.1%
Crosslink Ventures Capital LLC, Cl. A*,@,(b),(c)
   
111
     
2,775,000
 
(Cost $2,775,000)
           
2,775,000
 
Total Investments
(Cost $1,533,355,994)
   
98.7
%
 
$
2,945,636,095
 
Affiliated Securities (Cost $2,775,000)
           
2,775,000
 
Unaffiliated Securities (Cost $1,530,580,994)
           
2,942,861,095
 
Other Assets in Excess of Liabilities
   
1.3
%
   
38,886,661
 
NET ASSETS
   
100.0
%
 
$
2,984,522,756
 

#
American Depositary Receipts.
(a)
Restricted security - Security restricted from resale until the public disclosure of the company’s financial results for the period ended January 31, 2021.
(b)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(c)
Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 5 - Affiliated Securities.
*
Non-income producing security.

- 5 -

THE ALGER FUNDS
 
ALGER CAPITAL APPRECIATION FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)
 
@ Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.
 
 
 
Security
 
Acquisition Date(s)
 
Acquisition
Cost
   
% of net assets (Acquisition
Date)
   
Market
Value
   
% of net assets as of
1/31/2021
 
Altaba, Inc.
10/24/18
 
$
805,470
     
0.03
%
 
$
637,787
     
0.02
%
Altaba, Inc.
10/25/18
   
1,188,343
     
0.04
%
   
936,496
     
0.03
%
Altaba, Inc.
10/29/18
   
1,156,773
     
0.04
%
   
949,260
     
0.03
%
Altaba, Inc.
10/30/18
   
751,641
     
0.03
%
   
628,418
     
0.02
%
Altaba, Inc.
10/31/18
   
271,272
     
0.01
%
   
215,899
     
0.01
%
Altaba, Inc.
11/6/18
   
321,297
     
0.01
%
   
248,904
     
0.01
%
Crosslink Ventures Capital LLC, Cl. A
10/2/20
   
2,775,000
     
0.08
%
   
2,775,000
     
0.09
%
Palantir Technologies, Inc., Cl. A
10/1/20
   
4,530,544
     
0.13
%
   
20,709,014
     
0.70
%
Total
                   
$
27,100,778
     
0.91
%

See Notes to Financial Statements.

- 6 -

THE ALGER FUNDS
 
ALGER 25 FUND
Schedule of Investments January 31, 2021 (Unaudited)

COMMON STOCKS—99.5%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—2.3%
           
TransDigm Group, Inc.*
   
1,006
   
$
556,600
 
APPLICATION SOFTWARE—4.9%
               
Adobe, Inc.*
   
2,609
     
1,196,931
 
AUTOMOBILE MANUFACTURERS—2.0%
               
Tesla, Inc.*
   
616
     
488,814
 
CASINOS & GAMING—2.4%
               
DraftKings, Inc., Cl. A*
   
10,807
     
584,767
 
CONSUMER FINANCE—3.2%
               
dMY Technology Group, Inc. II, Cl. A*
   
37,085
     
769,514
 
DATA PROCESSING & OUTSOURCED SERVICES—9.9%
               
PayPal Holdings, Inc.*
   
5,154
     
1,207,634
 
Visa, Inc., Cl. A
   
6,133
     
1,185,202
 
             
2,392,836
 
FINANCIAL EXCHANGES & DATA—3.0%
               
S&P Global, Inc.
   
2,275
     
721,175
 
HEALTHCARE EQUIPMENT—3.1%
               
DexCom, Inc.*
   
758
     
284,136
 
Intuitive Surgical, Inc.*
   
626
     
468,023
 
             
752,159
 
INTERACTIVE MEDIA & SERVICES—12.2%
               
Alphabet, Inc., Cl. C*
   
764
     
1,402,505
 
Facebook, Inc., Cl. A*
   
3,532
     
912,422
 
Pinterest, Inc., Cl. A*
   
9,293
     
636,663
 
             
2,951,590
 
INTERNET & DIRECT MARKETING RETAIL—10.0%
               
Amazon.com, Inc.*
   
757
     
2,427,093
 
MANAGED HEALTHCARE—3.1%
               
UnitedHealth Group, Inc.
   
2,251
     
750,889
 
MOVIES & ENTERTAINMENT—1.5%
               
Live Nation Entertainment, Inc.*
   
5,579
     
370,724
 
RESTAURANTS—4.4%
               
Starbucks Corp.
   
11,000
     
1,064,910
 
SEMICONDUCTOR EQUIPMENT—3.7%
               
Applied Materials, Inc.
   
9,294
     
898,544
 
SEMICONDUCTORS—10.2%
               
Advanced Micro Devices, Inc.*
   
8,862
     
758,942
 
NVIDIA Corp.
   
1,291
     
670,791
 
Taiwan Semiconductor Manufacturing Co., Ltd.#
   
8,647
     
1,050,783
 
             
2,480,516
 
SPECIALTY CHEMICALS—2.5%
               
The Sherwin-Williams Co.
   
858
     
593,564
 
SYSTEMS SOFTWARE—9.5%
               
Microsoft Corp.
   
9,882
     
2,292,229
 

- 7 -

THE ALGER FUNDS
 
ALGER 25 FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—99.5% (CONT.)
 
SHARES
   
VALUE
 
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—8.2%
Apple, Inc.
   
15,026
   
$
1,982,831
 
WIRELESS TELECOMMUNICATION SERVICES—3.4%
T-Mobile US, Inc.*
   
6,537
     
824,185
 
TOTAL COMMON STOCKS
(Cost $16,801,048)
           
24,099,871
 
Total Investments
(Cost $16,801,048)
   
99.5
%
 
$
24,099,871
 
Unaffiliated Securities (Cost $16,801,048)
           
24,099,871
 
Other Assets in Excess of Liabilities
   
0.5
%
   
128,087
 
NET ASSETS
   
100.0
%
 
$
24,227,958
 

*
Non-income producing security. American Depositary Receipts.
#
American Depositary Receipts.

See Notes to Financial Statements.

- 8 -

THE ALGER FUNDS
 
ALGER 35 FUND
Schedule of Investments January 31, 2021 (Unaudited)

COMMON STOCKS—91.4%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—3.5%
           
HEICO Corp.
   
5,180
   
$
609,893
 
APPAREL RETAIL—0.9%
               
The TJX Cos., Inc.
   
2,412
     
154,464
 
APPLICATION SOFTWARE—4.8%
               
Adobe, Inc.*
   
1,396
     
640,443
 
Datadog, Inc., Cl. A*
   
1,822
     
187,210
 
             
827,653
 
AUTOMOBILE MANUFACTURERS—4.7%
               
Tesla, Inc.*
   
1,024
     
812,575
 
CASINOS & GAMING—2.6%
               
DraftKings, Inc., Cl. A*
   
8,249
     
446,353
 
CONSUMER FINANCE—4.7%
               
dMY Technology Group, Inc. II, Cl. A*
   
39,642
     
822,571
 
DATA PROCESSING & OUTSOURCED SERVICES—6.7%
 
PayPal Holdings, Inc.*
   
2,936
     
687,934
 
Square, Inc., Cl. A*
   
2,213
     
477,920
 
             
1,165,854
 
DIVERSIFIED BANKS—1.4%
               
JPMorgan Chase & Co.
   
1,883
     
242,286
 
FOOD DISTRIBUTORS—3.0%
               
US Foods Holding Corp.*
   
17,044
     
528,194
 
HEALTHCARE EQUIPMENT—6.3%
               
CryoPort, Inc.*
   
3,351
     
228,538
 
DexCom, Inc.*
   
443
     
166,059
 
Insulet Corp.*
   
965
     
257,829
 
Intuitive Surgical, Inc.*
   
585
     
437,369
 
             
1,089,795
 
HEALTHCARE TECHNOLOGY—3.5%
               
Teladoc Health, Inc.*
   
1,363
     
359,600
 
Veeva Systems, Inc., Cl. A*
   
899
     
248,520
 
             
608,120
 
INDUSTRIAL CONGLOMERATES—2.9%
               
General Electric Co.
   
47,218
     
504,288
 
INTERACTIVE MEDIA & SERVICES—7.2%
               
Alphabet, Inc., Cl. C*
   
486
     
892,169
 
Pinterest, Inc., Cl. A*
   
5,264
     
360,637
 
             
1,252,806
 
INTERNET & DIRECT MARKETING RETAIL—10.9%
               
Amazon.com, Inc.*
   
455
     
1,458,821
 
MercadoLibre, Inc.*
   
237
     
421,744
 
             
1,880,565
 
INTERNET SERVICES & INFRASTRUCTURE—2.9%
               
Shopify, Inc., Cl. A*
   
454
     
498,760
 
LEISURE FACILITIES—2.6%
               
Vail Resorts, Inc.
   
1,675
     
445,483
 

- 9 -

THE ALGER FUNDS
 
ALGER 35 FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—91.4% (CONT.)
 
SHARES
   
VALUE
 
LIFE SCIENCES TOOLS & SERVICES—2.0%
Bio-Techne Corp.
   
1,066
   
$
346,354
 
MOVIES & ENTERTAINMENT—1.2%
Netflix, Inc.*
   
405
     
215,618
 
RESEARCH & CONSULTING SERVICES—1.8%
CoStar Group, Inc.*
   
344
     
309,500
 
SEMICONDUCTOR EQUIPMENT—3.0%
Applied Materials, Inc.
   
5,367
     
518,882
 
SEMICONDUCTORS—6.0%
Advanced Micro Devices, Inc.*
   
3,459
     
296,229
 
QUALCOMM, Inc.
   
3,792
     
592,614
 
Universal Display Corp.
   
676
     
156,034
 
             
1,044,877
 
SYSTEMS SOFTWARE—1.2%
Crowdstrike Holdings, Inc., Cl. A*
   
940
     
202,852
 
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—7.6%
Apple, Inc.
   
9,951
     
1,313,134
 
TOTAL COMMON STOCKS
(Cost $11,442,753)
           
15,840,877
 
REAL ESTATE INVESTMENT TRUST—4.7%
 
SHARES
   
VALUE
 
RETAIL—2.1%
Simon Property Group, Inc.
   
3,936
     
365,772
 
SPECIALIZED—2.6%
Crown Castle International Corp.
   
2,799
     
445,769
 
TOTAL REAL ESTATE INVESTMENT TRUST
(Cost $799,310)
           
811,541
 
Total Investments
(Cost $12,242,063)
   
96.1
%
 
$
16,652,418
 
Unaffiliated Securities (Cost $12,242,063)
           
16,652,418
 
Other Assets in Excess of Liabilities
   
3.9
%
   
671,728
 
NET ASSETS
   
100.0
%
 
$
17,324,146
 

*
Non-income producing security.

See Notes to Financial Statements.

- 10 -

THE ALGER FUNDS
 
ALGER GROWTH & INCOME FUND
Schedule of Investments January 31, 2021 (Unaudited)

COMMON STOCKS—94.1%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—1.6%
           
General Dynamics Corp.
   
4,078
   
$
598,161
 
Raytheon Technologies Corp.
   
8,937
     
596,366
 
TransDigm Group, Inc.*
   
1,455
     
805,022
 
             
1,999,549
 
ASSET MANAGEMENT & CUSTODY BANKS—3.7%
               
BlackRock, Inc., Cl. A
   
3,473
     
2,435,476
 
The Blackstone Group, Inc., Cl. A
   
21,938
     
1,474,014
 
The Carlyle Group, Inc.
   
22,818
     
736,337
 
             
4,645,827
 
BIOTECHNOLOGY—2.5%
               
AbbVie, Inc.
   
15,134
     
1,550,932
 
Amgen, Inc.
   
3,959
     
955,821
 
Gilead Sciences, Inc.
   
9,368
     
614,541
 
             
3,121,294
 
BROADCASTING—0.5%
               
ViacomCBS, Inc., Cl. B
   
12,912
     
626,232
 
BUILDING PRODUCTS—0.5%
               
Johnson Controls International PLC
   
13,534
     
674,264
 
CABLE & SATELLITE—1.5%
               
Comcast Corp., Cl. A
   
36,605
     
1,814,510
 
COMMODITY CHEMICALS—0.3%
               
Dow, Inc.
   
8,245
     
427,915
 
COMMUNICATIONS EQUIPMENT—1.2%
               
Cisco Systems, Inc.
   
32,297
     
1,439,800
 
COMPUTER & ELECTRONICS RETAIL—0.5%
               
Best Buy Co., Inc.
   
5,340
     
581,099
 
CONSTRUCTION MACHINERY & HEAVY TRUCKS—0.2%
 
PACCAR, Inc.
   
3,193
     
291,265
 
CONSUMER ELECTRONICS—0.6%
               
Garmin Ltd.
   
6,386
     
733,496
 
DATA PROCESSING & OUTSOURCED SERVICES—1.2%
 
Visa, Inc., Cl. A
   
7,913
     
1,529,187
 
DIVERSIFIED BANKS—5.2%
               
Bank of America Corp.
   
51,526
     
1,527,746
 
JPMorgan Chase & Co.
   
38,992
     
5,017,101
 
             
6,544,847
 
ELECTRIC UTILITIES—0.8%
               
NextEra Energy, Inc.
   
13,080
     
1,057,780
 
ELECTRICAL COMPONENTS & EQUIPMENT—0.9%
               
Eaton Corp. PLC
   
9,174
     
1,079,780
 
FINANCIAL EXCHANGES & DATA—1.2%
               
CME Group, Inc., Cl. A
   
8,072
     
1,467,005
 
FOOD DISTRIBUTORS—0.6%
               
Sysco Corp.
   
10,761
     
769,519
 

- 11 -

THE ALGER FUNDS
 
ALGER GROWTH & INCOME FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—94.1% (CONT.)
 
SHARES
   
VALUE
 
HEALTHCARE EQUIPMENT—0.7%
           
Medtronic PLC
   
7,677
   
$
854,680
 
HEALTHCARE SERVICES—1.1%
               
CVS Health Corp.
   
19,361
     
1,387,216
 
HOME IMPROVEMENT RETAIL—3.2%
               
The Home Depot, Inc.
   
14,637
     
3,963,992
 
HOUSEHOLD PRODUCTS—1.7%
               
The Procter & Gamble Co.
   
16,512
     
2,117,004
 
HYPERMARKETS & SUPER CENTERS—1.0%
               
Walmart, Inc.
   
8,590
     
1,206,809
 
INDUSTRIAL CONGLOMERATES—2.2%
               
Honeywell International, Inc.
   
14,038
     
2,742,604
 
INDUSTRIAL GASES—1.2%
               
Air Products & Chemicals, Inc.
   
5,816
     
1,551,476
 
INTEGRATED OIL & GAS—1.9%
               
Chevron Corp.
   
15,195
     
1,294,614
 
Exxon Mobil Corp.
   
7,053
     
316,257
 
TOTAL SE#,(a)
   
18,551
     
780,626
 
             
2,391,497
 
INTEGRATED TELECOMMUNICATION SERVICES—2.4%
               
AT&T, Inc.
   
31,054
     
889,076
 
Verizon Communications, Inc.
   
37,786
     
2,068,784
 
             
2,957,860
 
INTERACTIVE MEDIA & SERVICES—7.9%
               
Alphabet, Inc., Cl. A*
   
2,002
     
3,658,375
 
Alphabet, Inc., Cl. C*
   
1,941
     
3,563,171
 
Facebook, Inc., Cl. A*
   
10,523
     
2,718,407
 
             
9,939,953
 
INTERNET & DIRECT MARKETING RETAIL—2.5%
               
Amazon.com, Inc.*
   
981
     
3,145,282
 
INVESTMENT BANKING & BROKERAGE—2.5%
               
Morgan Stanley
   
45,840
     
3,073,572
 
LEISURE FACILITIES—0.4%
               
Vail Resorts, Inc.
   
2,038
     
542,026
 
MANAGED HEALTHCARE—2.1%
               
UnitedHealth Group, Inc.
   
8,036
     
2,680,649
 
MULTI-LINE INSURANCE—0.4%
               
The Hartford Financial Services Group, Inc.
   
9,936
     
477,127
 
MULTI-UTILITIES—0.5%
               
Sempra Energy
   
5,217
     
645,656
 
OIL & GAS STORAGE & TRANSPORTATION—0.3%
               
ONEOK, Inc.
   
10,099
     
402,243
 
PHARMACEUTICALS—7.4%
               
AstraZeneca PLC#
   
19,380
     
980,628
 
Bristol-Myers Squibb Co.
   
13,462
     
826,971
 

- 12 -

THE ALGER FUNDS
 
ALGER GROWTH & INCOME FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—94.1% (CONT.)
 
SHARES
   
VALUE
 
PHARMACEUTICALS—7.4% (CONT.)
           
Eli Lilly & Co.
   
6,696
   
$
1,392,567
 
GlaxoSmithKline PLC#
   
19,014
     
708,272
 
Johnson & Johnson
   
16,211
     
2,644,500
 
Merck & Co., Inc.
   
10,553
     
813,320
 
Novartis AG#
   
8,155
     
737,783
 
Pfizer, Inc.
   
26,928
     
966,715
 
Viatris, Inc.*
   
14,256
     
242,209
 
             
9,312,965
 
PROPERTY & CASUALTY INSURANCE—0.5%
               
The Progressive Corp.
   
6,523
     
568,740
 
RAILROADS—0.8%
               
Union Pacific Corp.
   
4,822
     
952,200
 
RESTAURANTS—1.3%
               
McDonald's Corp.
   
4,437
     
922,186
 
Starbucks Corp.
   
7,343
     
710,876
 
             
1,633,062
 
SEMICONDUCTOR EQUIPMENT—2.1%
               
KLA Corp.
   
9,338
     
2,615,294
 
SEMICONDUCTORS—4.9%
               
Broadcom, Inc.
   
5,840
     
2,630,920
 
QUALCOMM, Inc.
   
14,425
     
2,254,339
 
Taiwan Semiconductor Manufacturing Co., Ltd.#
   
10,109
     
1,228,446
 
             
6,113,705
 
SOFT DRINKS—2.7%
               
PepsiCo, Inc.
   
13,527
     
1,847,382
 
The Coca-Cola Co.
   
30,625
     
1,474,594
 
             
3,321,976
 
SYSTEMS SOFTWARE—9.3%
               
Microsoft Corp.
   
50,401
     
11,691,016
 
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—8.8%
 
Apple, Inc.
   
82,945
     
10,945,422
 
TOBACCO—1.3%
               
Altria Group, Inc.
   
26,806
     
1,101,191
 
Philip Morris International, Inc.
   
6,888
     
548,629
 
             
1,649,820
 
TOTAL COMMON STOCKS
               
(Cost $48,793,437)
           
117,687,215
 
MASTER LIMITED PARTNERSHIP—0.5%
 
SHARES
   
VALUE
 
OIL & GAS STORAGE & TRANSPORTATION—0.5%
               
Cheniere Energy Partners LP
   
17,250
     
675,165
 
(Cost $584,260)
           
675,165
 
REAL ESTATE INVESTMENT TRUST—4.4%
 
SHARES
   
VALUE
 
HEALTHCARE—0.5%
               
Welltower, Inc.
   
10,370
     
628,422
 

- 13 -

THE ALGER FUNDS
 
ALGER GROWTH & INCOME FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

REAL ESTATE INVESTMENT TRUST—4.4% (CONT.)
SHARES
 
VALUE
 
INDUSTRIAL—0.5%
Americold Realty Trust
   
19,006
   
$
663,500
 
MORTGAGE—0.7%
Blackstone Mortgage Trust, Inc., Cl. A
   
33,724
     
899,082
 
SPECIALIZED—2.7%
Crown Castle International Corp.
   
11,141
     
1,774,316
 
CyrusOne, Inc.
   
9,552
     
696,818
 
Lamar Advertising Co., Cl. A
   
10,535
     
851,017
 
             
3,322,151
 
TOTAL REAL ESTATE INVESTMENT TRUST
(Cost $3,966,754)
           
5,513,155
 
SHORT—TERM INVESTMENTS—0.1%
SHARES
 
VALUE
 
MONEY MARKET FUND—0.1%
Invesco Government & Agency Portfolio, Cl. Institutional, 0.03%
   
66,750
     
66,750
 
(Cost $66,750)
           
66,750
 
Total Investments
(Cost $53,411,201)
   
99.1
%
 
$
123,942,285
 
Unaffiliated Securities (Cost $53,411,201)
           
123,942,285
 
Other Assets in Excess of Liabilities
   
0.9
%
   
1,093,838
 
NET ASSETS
   
100.0
%
 
$
125,036,123
 

#
American Depositary Receipts.
(a)
All or portion of the security is on loan.
*
Non-income producing security.

- 14 -

THE ALGER FUNDS
 
ALGER MID CAP GROWTH FUND
Schedule of Investments January 31, 2021 (Unaudited)
 
COMMON STOCKS—92.1%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—2.1%
           
HEICO Corp.
   
27,185
   
$
3,200,762
 
Teledyne Technologies, Inc.*
   
3,753
     
1,339,858
 
TransDigm Group, Inc.*
   
2,657
     
1,470,065
 
             
6,010,685
 
AGRICULTURAL & FARM MACHINERY—0.6%
               
Hydrofarm Holdings Group, Inc.*
   
21,657
     
1,635,320
 
AIR FREIGHT & LOGISTICS—0.7%
               
XPO Logistics, Inc.*
   
17,978
     
1,984,951
 
APPAREL ACCESSORIES & LUXURY GOODS—1.3%
               
Capri Holdings Ltd.*
   
34,365
     
1,431,646
 
Moncler SpA*
   
43,837
     
2,470,107
 
             
3,901,753
 
APPAREL RETAIL—0.5%
               
Burlington Stores, Inc.*
   
5,422
     
1,349,536
 
APPLICATION SOFTWARE—15.1%
               
ANSYS, Inc.*
   
8,283
     
2,935,247
 
Atlassian Corp. PLC, Cl. A*
   
8,849
     
2,045,269
 
Avalara, Inc.*
   
14,071
     
2,110,650
 
Benefitfocus, Inc.*
   
71,827
     
883,472
 
Cadence Design Systems, Inc.*
   
28,183
     
3,674,781
 
Coupa Software, Inc.*
   
9,765
     
3,025,881
 
Datadog, Inc., Cl. A*
   
29,568
     
3,038,112
 
DocuSign, Inc., Cl. A*
   
20,028
     
4,664,321
 
Dynatrace, Inc.*
   
48,242
     
2,002,525
 
Fair Isaac Corp.*
   
4,203
     
1,891,812
 
Five9, Inc.*
   
25,930
     
4,310,863
 
MicroStrategy, Inc., Cl. A*
   
3,266
     
2,016,134
 
Palantir Technologies, Inc., Cl. A*,@,(a)
   
73,492
     
2,212,499
 
Paycom Software, Inc.*
   
8,198
     
3,113,109
 
PTC, Inc.*
   
34,919
     
4,641,084
 
Sprout Social, Inc., Cl. A*
   
24,000
     
1,584,000
 
             
44,149,759
 
BIOTECHNOLOGY—4.7%
               
BioMarin Pharmaceutical, Inc.*
   
16,903
     
1,399,231
 
Exact Sciences Corp.*
   
9,187
     
1,260,089
 
Forte Biosciences, Inc.*
   
91,707
     
3,105,199
 
Incyte Corp.*
   
16,188
     
1,452,873
 
Invitae Corp.*
   
62,800
     
3,109,856
 
Natera, Inc.*
   
32,591
     
3,475,504
 
             
13,802,752
 
CASINOS & GAMING—3.4%
               
DraftKings, Inc., Cl. A*
   
90,416
     
4,892,410
 
Flutter Entertainment PLC*
   
6,791
     
1,263,059
 
Penn National Gaming, Inc.*
   
37,662
     
3,906,302
 
             
10,061,771
 

- 15 -

THE ALGER FUNDS
 
ALGER MID CAP GROWTH FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)
 
COMMON STOCKS—92.1% (CONT.)
 
SHARES
   
VALUE
 
CONSUMER FINANCE—1.7%
           
dMY Technology Group, Inc. II, Cl. A*
   
239,427
   
$
4,968,110
 
DATA PROCESSING & OUTSOURCED SERVICES—1.8%
 
Square, Inc., Cl. A*
   
24,378
     
5,264,673
 
DISTRIBUTORS—0.5%
               
Pool Corp.
   
3,876
     
1,372,802
 
DIVERSIFIED SUPPORT SERVICES—1.9%
               
Cintas Corp.
   
5,457
     
1,735,981
 
Copart, Inc.*
   
33,733
     
3,702,197
 
             
5,438,178
 
EDUCATION SERVICES—0.6%
               
Chegg, Inc.*
   
18,027
     
1,717,252
 
ELECTRICAL COMPONENTS & EQUIPMENT—1.0%
               
AMETEK, Inc.
   
13,094
     
1,483,027
 
Generac Holdings, Inc.*
   
6,146
     
1,514,497
 
             
2,997,524
 
ELECTRONIC EQUIPMENT & INSTRUMENTS—1.3%
               
Trimble, Inc.*
   
57,091
     
3,762,868
 
FERTILIZERS & AGRICULTURAL CHEMICALS—0.7%
               
The Scotts Miracle-Gro Co.
   
9,175
     
2,031,437
 
FINANCIAL EXCHANGES & DATA—0.5%
               
MarketAxess Holdings, Inc.
   
2,965
     
1,603,353
 
FOOD DISTRIBUTORS—1.1%
               
US Foods Holding Corp.*
   
108,032
     
3,347,912
 
HEALTHCARE EQUIPMENT—4.7%
               
ABIOMED, Inc.*
   
4,988
     
1,737,071
 
CryoPort, Inc.*
   
42,149
     
2,874,562
 
DexCom, Inc.*
   
5,910
     
2,215,364
 
Insulet Corp.*
   
12,853
     
3,434,065
 
Masimo Corp.*
   
8,758
     
2,241,347
 
Nevro Corp.*
   
7,774
     
1,257,755
 
             
13,760,164
 
HEALTHCARE SERVICES—1.5%
               
Guardant Health, Inc.*
   
27,936
     
4,344,048
 
HEALTHCARE SUPPLIES—1.3%
               
Align Technology, Inc.*
   
7,139
     
3,750,688
 
HEALTHCARE TECHNOLOGY—3.0%
               
Teladoc Health, Inc.*
   
15,576
     
4,109,416
 
Veeva Systems, Inc., Cl. A*
   
17,311
     
4,785,453
 
             
8,894,869
 
HOMEFURNISHING RETAIL—0.8%
               
Williams-Sonoma, Inc.
   
19,331
     
2,492,153
 
HOTELS RESORTS & CRUISE LINES—0.4%
               
Extended Stay America, Inc.
   
82,925
     
1,217,339
 

- 16 -

THE ALGER FUNDS
 
ALGER MID CAP GROWTH FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)
 
COMMON STOCKS—92.1% (CONT.)
 
SHARES
   
VALUE
 
HUMAN RESOURCE & EMPLOYMENT SERVICES—0.7%
 
Upwork, Inc.*
   
51,889
   
$
2,150,799
 
INDUSTRIAL MACHINERY—1.0%
               
The Middleby Corp.*
   
21,156
     
2,871,292
 
INTERACTIVE HOME ENTERTAINMENT—1.9%
               
Activision Blizzard, Inc.
   
24,262
     
2,207,842
 
Skillz, Inc.*
   
122,544
     
3,384,665
 
             
5,592,507
 
INTERACTIVE MEDIA & SERVICES—1.8%
               
Pinterest, Inc., Cl. A*
   
78,948
     
5,408,727
 
INTERNET & DIRECT MARKETING RETAIL—5.3%
               
Etsy, Inc.*
   
12,317
     
2,452,192
 
Farfetch Ltd., Cl. A*
   
64,524
     
3,951,450
 
Fiverr International Ltd.*
   
6,873
     
1,419,343
 
Magnite, Inc.*
   
138,360
     
4,792,790
 
MercadoLibre, Inc.*
   
1,678
     
2,986,018
 
             
15,601,793
 
INTERNET SERVICES & INFRASTRUCTURE—3.8%
               
BigCommerce Holdings, Inc.*
   
72,240
     
5,774,866
 
Okta, Inc., Cl. A*
   
14,523
     
3,761,602
 
Twilio, Inc., Cl. A*
   
4,384
     
1,575,741
 
             
11,112,209
 
LEISURE FACILITIES—0.9%
               
Vail Resorts, Inc.
   
9,606
     
2,554,812
 
LEISURE PRODUCTS—0.7%
               
Peloton Interactive, Inc., Cl. A*
   
14,379
     
2,101,203
 
LIFE SCIENCES TOOLS & SERVICES—3.7%
               
10X Genomics, Inc., Cl. A*
   
16,667
     
2,852,557
 
Bio-Techne Corp.
   
15,284
     
4,965,924
 
Repligen Corp.*
   
14,474
     
2,894,800
 
             
10,713,281
 
METAL & GLASS CONTAINERS—0.5%
               
Ball Corp.
   
15,472
     
1,361,845
 
MOVIES & ENTERTAINMENT—2.7%
               
Live Nation Entertainment, Inc.*
   
11,241
     
746,964
 
Roku, Inc., Cl. A*
   
18,250
     
7,099,797
 
             
7,846,761
 
PHARMACEUTICALS—2.0%
               
Catalent, Inc.*
   
19,794
     
2,277,300
 
Green Thumb Industries, Inc.*
   
127,666
     
3,699,509
 
             
5,976,809
 
REGIONAL BANKS—1.0%
               
SVB Financial Group*
   
6,559
     
2,871,399
 
RESEARCH & CONSULTING SERVICES—2.6%
               
CoStar Group, Inc.*
   
4,382
     
3,942,529
 

- 17 -

THE ALGER FUNDS
 
ALGER MID CAP GROWTH FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)
 
COMMON STOCKS—92.1% (CONT.)
 
SHARES
   
VALUE
 
RESEARCH & CONSULTING SERVICES—2.6% (CONT.)
           
Verisk Analytics, Inc., Cl. A
   
20,040
   
$
3,677,340
 
             
7,619,869
 
RESTAURANTS—1.6%
               
Chipotle Mexican Grill, Inc., Cl. A*
   
1,978
     
2,927,440
 
Shake Shack, Inc., Cl. A*
   
15,684
     
1,778,879
 
             
4,706,319
 
SEMICONDUCTOR EQUIPMENT—2.9%
               
KLA Corp.
   
7,762
     
2,173,903
 
Lam Research Corp.
   
7,372
     
3,567,679
 
SolarEdge Technologies, Inc.*
   
10,026
     
2,890,797
 
             
8,632,379
 
SEMICONDUCTORS—3.4%
               
Advanced Micro Devices, Inc.*
   
45,977
     
3,937,470
 
Microchip Technology, Inc.
   
20,162
     
2,744,250
 
Universal Display Corp.
   
13,747
     
3,173,083
 
             
9,854,803
 
SYSTEMS SOFTWARE—2.6%
               
Crowdstrike Holdings, Inc., Cl. A*
   
25,558
     
5,515,416
 
Palo Alto Networks, Inc.*
   
5,590
     
1,960,693
 
             
7,476,109
 
TRUCKING—1.8%
               
Old Dominion Freight Line, Inc.
   
10,731
     
2,081,814
 
Uber Technologies, Inc.*
   
63,654
     
3,241,898
 
             
5,323,712
 
TOTAL COMMON STOCKS
               
(Cost $186,705,625)
           
269,636,525
 
PREFERRED STOCKS—0.0%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%
               
Prosetta Biosciences, Inc., Series D*,@,(b),(c)
   
219,610
     
32,942
 
(Cost $988,245)
           
32,942
 
WARRANTS—1.5%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—1.5%
               
Forte Biosciences, Inc., 2/20/21*,@
   
193,270
     
4,502,418
 
(Cost $0)
           
4,502,418
 
RIGHTS—0.1%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.1%
               
Tolero CDR*,@,(b),(d)
   
590,059
     
407,141
 
(Cost $315,501)
           
407,141
 
REAL ESTATE INVESTMENT TRUST—4.8%
 
SHARES
   
VALUE
 
RETAIL—2.2%
               
Simon Property Group, Inc.
   
31,061
     
2,886,499
 
Tanger Factory Outlet Centers, Inc.
   
227,968
     
3,517,546
 
             
6,404,045
 

- 18 -

THE ALGER FUNDS
 
ALGER MID CAP GROWTH FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

REAL ESTATE INVESTMENT TRUST—4.8% (CONT.)
 
SHARES
   
VALUE
 
SPECIALIZED—2.6%
           
Crown Castle International Corp.
   
47,449
   
$
7,556,728
 
TOTAL REAL ESTATE INVESTMENT TRUST
               
(Cost $12,888,249)
           
13,960,773
 
SPECIAL PURPOSE VEHICLE—0.6%
 
SHARES
   
VALUE
 
DATA PROCESSING & OUTSOURCED SERVICES—0.6%
               
Crosslink Ventures Capital LLC, Cl. A*,@,(b),(c)
   
48
     
1,200,000
 
Crosslink Ventures Capital LLC, Cl. B*,@,(b),(c)
   
19
     
475,000
 
             
1,675,000
 
TOTAL SPECIAL PURPOSE VEHICLE
               
(Cost $1,675,000)
           
1,675,000
 
Total Investments
               
(Cost $202,572,620)
   
99.1
%
 
$
290,214,799
 
Affiliated Securities (Cost $2,663,245)
           
1,707,942
 
Unaffiliated Securities (Cost $199,909,375)
           
288,506,857
 
Other Assets in Excess of Liabilities
   
0.9
%
   
2,563,219
 
NET ASSETS
   
100.0
%
 
$
292,778,018
 
 
(a) Restricted security - Security restricted from resale until the public disclosure of the company’s financial results for the period ended January 31, 2021.
(b) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(c) Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 5 - Affiliated Securities.
(d) Contingent Deferred Rights.
*    Non-income producing security.
@ Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.
 
 
 
Security
 
Acquisition Date(s)
 
Acquisition
Cost
   
% of net assets (Acquisition
Date)
   
Market
Value
   
% of net assets as of
1/31/2021
 
Crosslink Ventures Capital LLC, Cl. A
10/2/20
 
$
1,200,000
     
0.50
%
 
$
1,200,000
     
0.41
%
Crosslink Ventures Capital LLC, Cl. B
12/16/20
   
475,000
     
0.19
%
   
475,000
     
0.16
%
Forte Biosciences, Inc., Warrants
2/19/20
   
0
     
0.00
%
   
4,502,418
     
1.54
%
Palantir Technologies, Inc., Cl. A
10/1/20
   
483,715
     
0.20
%
   
2,212,499
     
0.76
%
Prosetta Biosciences, Inc., Series D
2/6/15
   
988,245
     
0.50
%
   
32,942
     
0.01
%
Tolero CDR
2/6/17
   
315,501
     
0.19
%
   
407,141
     
0.14
%
Total
                   
$
8,830,000
     
3.02
%

See Notes to Financial Statements.

- 19 -

THE ALGER FUNDS
 
ALGER MID CAP FOCUS FUND
Schedule of Investments January 31, 2021 (Unaudited)

COMMON STOCKS—91.9%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—2.9%
           
EHang Holdings Ltd.#,*
   
108,070
   
$
7,171,525
 
HEICO Corp., Cl. A
   
102,986
     
10,948,442
 
             
18,119,967
 
AGRICULTURAL & FARM MACHINERY—1.2%
               
Hydrofarm Holdings Group, Inc.*
   
101,761
     
7,683,973
 
AIR FREIGHT & LOGISTICS—1.5%
               
XPO Logistics, Inc.*
   
82,459
     
9,104,298
 
APPAREL ACCESSORIES & LUXURY GOODS—1.1%
               
Capri Holdings Ltd.*
   
160,779
     
6,698,053
 
APPAREL RETAIL—1.7%
               
Burlington Stores, Inc.*
   
42,265
     
10,519,758
 
APPLICATION SOFTWARE—14.4%
               
Anaplan, Inc.*
   
154,272
     
10,289,942
 
Bentley Systems, Inc., Cl. B
   
272,209
     
10,695,092
 
Cloudera, Inc.*
   
921,931
     
14,077,886
 
DocuSign, Inc., Cl. A*
   
48,338
     
11,257,437
 
Dynatrace, Inc.*
   
184,834
     
7,672,459
 
Manhattan Associates, Inc.*
   
99,998
     
11,322,774
 
MicroStrategy, Inc., Cl. A*
   
21,661
     
13,371,552
 
RingCentral, Inc., Cl. A*
   
29,170
     
10,878,076
 
             
89,565,218
 
ASSET MANAGEMENT & CUSTODY BANKS—3.7%
               
Star Peak Energy Transition Corp., Cl. A*
   
433,452
     
11,746,549
 
Switchback Energy Acquisition Corp., Cl. A*
   
293,328
     
11,164,064
 
             
22,910,613
 
BIOTECHNOLOGY—5.6%
               
DermTech, Inc.*
   
221,304
     
9,069,038
 
Exact Sciences Corp.*
   
59,613
     
8,176,519
 
Invitae Corp.*
   
357,603
     
17,708,501
 
             
34,954,058
 
CASINOS & GAMING—5.3%
               
DraftKings, Inc., Cl. A*
   
294,568
     
15,939,075
 
Penn National Gaming, Inc.*
   
166,227
     
17,241,064
 
             
33,180,139
 
CONSUMER FINANCE—2.0%
               
dMY Technology Group, Inc. II, Cl. A*
   
604,862
     
12,550,886
 
DATA PROCESSING & OUTSOURCED SERVICES—1.6%
               
Square, Inc., Cl. A*
   
45,529
     
9,832,443
 
DISTRIBUTORS—1.5%
               
Pool Corp.
   
26,051
     
9,226,743
 
ELECTRICAL COMPONENTS & EQUIPMENT—1.9%
               
Generac Holdings, Inc.*
   
47,330
     
11,663,059
 
HEALTHCARE SERVICES—1.3%
               
1Life Healthcare, Inc.*
   
164,695
     
8,333,567
 

- 20 -

THE ALGER FUNDS
 
ALGER MID CAP FOCUS FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—91.9% (CONT.)
 
SHARES
   
VALUE
 
HEALTHCARE SUPPLIES—1.1%
           
Align Technology, Inc.*
   
12,702
   
$
6,673,377
 
HEALTHCARE TECHNOLOGY—2.8%
               
Renalytix AI PLC#,*
   
284,279
     
7,442,424
 
Veeva Systems, Inc., Cl. A*
   
37,114
     
10,259,794
 
             
17,702,218
 
HOME IMPROVEMENT RETAIL—1.6%
               
GrowGeneration Corp.*
   
230,566
     
9,958,145
 
INDUSTRIAL MACHINERY—5.7%
               
Colfax Corp.*
   
318,900
     
11,837,568
 
Helios Technologies, Inc.
   
202,104
     
11,024,773
 
The Middleby Corp.*
   
91,523
     
12,421,502
 
             
35,283,843
 
INTERACTIVE MEDIA & SERVICES—2.5%
               
Pinterest, Inc., Cl. A*
   
222,279
     
15,228,334
 
INTERNET & DIRECT MARKETING RETAIL—13.2%
               
Chewy, Inc., Cl. A*
   
102,655
     
10,452,332
 
Farfetch Ltd., Cl. A*
   
249,755
     
15,294,996
 
Fiverr International Ltd.*
   
36,488
     
7,535,137
 
Magnite, Inc.*
   
602,421
     
20,867,864
 
MercadoLibre, Inc.*
   
9,173
     
16,323,445
 
Pinduoduo, Inc.#,*
   
71,604
     
11,865,499
 
             
82,339,273
 
INTERNET SERVICES & INFRASTRUCTURE—1.5%
               
Shopify, Inc., Cl. A*
   
8,445
     
9,277,593
 
LIFE SCIENCES TOOLS & SERVICES—1.7%
               
Quanterix Corp.*
   
162,516
     
10,521,286
 
MOVIES & ENTERTAINMENT—2.8%
               
Roku, Inc., Cl. A*
   
45,255
     
17,605,553
 
PAPER PACKAGING—1.0%
               
Ranpak Holdings Corp., Cl. A*
   
349,797
     
6,065,480
 
SEMICONDUCTOR EQUIPMENT—1.7%
               
Enphase Energy, Inc.*
   
57,916
     
10,560,983
 
SEMICONDUCTORS—1.6%
               
Universal Display Corp.
   
41,917
     
9,675,282
 
SYSTEMS SOFTWARE—7.5%
               
Cloudflare, Inc., Cl. A*
   
209,319
     
16,046,395
 
Crowdstrike Holdings, Inc., Cl. A*
   
81,975
     
17,690,205
 
Telos Corp.*
   
370,685
     
13,085,180
 
             
46,821,780
 
TRADING COMPANIES & DISTRIBUTORS—1.5%
               
SiteOne Landscape Supply, Inc.*
   
59,822
     
9,432,733
 
TOTAL COMMON STOCKS
               
(Cost $438,072,369)
           
571,488,655
 

- 21 -

THE ALGER FUNDS
 
ALGER MID CAP FOCUS FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)
 
     
VALUE
 
Total Investments
(Cost $438,072,369)
   
91.9
%
 
$
571,488,655
 
Unaffiliated Securities (Cost $438,072,369)
           
571,488,655
 
Other Assets in Excess of Liabilities
   
8.1
%
   
50,385,249
 
NET ASSETS
   
100.0
%
 
$
621,873,904
 

#
American Depositary Receipts.
*
Non-income producing security.

See Notes to Financial Statements.

- 22 -

THE ALGER FUNDS
 
ALGER WEATHERBIE SPECIALIZED GROWTH FUND
Schedule of Investments January 31, 2021 (Unaudited)

COMMON STOCKS—98.2%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—1.5%
           
Kratos Defense & Security Solutions, Inc.*
   
769,454
   
$
20,421,309
 
AIR FREIGHT & LOGISTICS—1.2%
               
XPO Logistics, Inc.*
   
145,052
     
16,015,191
 
APPAREL ACCESSORIES & LUXURY GOODS—0.1%
               
Canada Goose Holdings, Inc.*
   
58,210
     
1,947,707
 
APPAREL RETAIL—0.4%
               
MYT Netherlands Parent BV#,*
   
156,137
     
5,140,030
 
APPLICATION SOFTWARE—16.8%
               
Altair Engineering, Inc., Cl. A*
   
55,276
     
3,091,587
 
Avalara, Inc.*
   
128,063
     
19,209,450
 
Bill.com Holdings, Inc.*
   
34,781
     
4,239,108
 
Cerence, Inc.*
   
312,578
     
34,980,604
 
Ebix, Inc.
   
479,412
     
24,962,983
 
Everbridge, Inc.*
   
189,310
     
25,164,978
 
LivePerson, Inc.*
   
83,658
     
5,300,571
 
Mimecast Ltd.*
   
145,007
     
6,244,001
 
Paylocity Holding Corp.*
   
342,047
     
64,120,131
 
SPS Commerce, Inc.*
   
125,089
     
12,370,051
 
Vertex, Inc., Cl. A*
   
811,105
     
26,644,799
 
             
226,328,263
 
ASSET MANAGEMENT & CUSTODY BANKS—4.4%
               
Hamilton Lane, Inc., Cl. A
   
385,653
     
29,066,667
 
StepStone Group, Inc., Cl. A*
   
858,725
     
30,158,422
 
             
59,225,089
 
BIOTECHNOLOGY—10.4%
               
ACADIA Pharmaceuticals, Inc.*
   
916,853
     
44,054,787
 
Natera, Inc.*
   
647,613
     
69,061,451
 
Puma Biotechnology, Inc.*
   
1,380,976
     
16,212,658
 
Ultragenyx Pharmaceutical, Inc.*
   
72,548
     
10,054,427
 
             
139,383,323
 
CONSUMER FINANCE—3.5%
               
LendingTree, Inc.*
   
37,563
     
12,227,508
 
Upstart Holdings, Inc.*
   
571,483
     
35,540,528
 
             
47,768,036
 
EDUCATION SERVICES—6.0%
               
Chegg, Inc.*
   
844,109
     
80,409,823
 
ELECTRONIC EQUIPMENT & INSTRUMENTS—0.6%
               
Novanta, Inc.*
   
60,066
     
7,503,445
 
ENVIRONMENTAL & FACILITIES SERVICES—3.6%
               
Casella Waste Systems, Inc., Cl. A*
   
616,761
     
35,303,399
 
Montrose Environmental Group, Inc.*
   
368,117
     
13,612,967
 
             
48,916,366
 
GENERAL MERCHANDISE STORES—3.8%
               
Ollie's Bargain Outlet Holdings, Inc.*
   
534,135
     
50,598,609
 

- 23 -

THE ALGER FUNDS
 
ALGER WEATHERBIE SPECIALIZED GROWTH FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—98.2% (CONT.)
 
SHARES
   
VALUE
 
HEALTHCARE DISTRIBUTORS—1.3%
           
PetIQ, Inc., Cl. A*
   
522,154
   
$
18,097,858
 
HEALTHCARE EQUIPMENT—7.5%
               
Eargo, Inc.*
   
322,818
     
16,973,770
 
Glaukos Corp.*
   
264,931
     
23,496,730
 
Nevro Corp.*
   
373,911
     
60,495,061
 
             
100,965,561
 
HEALTHCARE FACILITIES—1.0%
               
US Physical Therapy, Inc.
   
109,951
     
13,231,503
 
HEALTHCARE SUPPLIES—0.6%
               
BioLife Solutions, Inc.*
   
55,938
     
2,121,169
 
Silk Road Medical, Inc.*
   
110,418
     
6,021,093
 
             
8,142,262
 
HEALTHCARE TECHNOLOGY—2.2%
               
Inspire Medical Systems, Inc.*
   
13,172
     
2,654,290
 
Tabula Rasa HealthCare, Inc.*
   
478,489
     
27,173,390
 
             
29,827,680
 
INSURANCE BROKERS—1.9%
               
Goosehead Insurance, Inc., Cl. A
   
189,931
     
25,374,782
 
IT CONSULTING & OTHER SERVICES—2.2%
               
Globant SA*
   
157,205
     
30,183,360
 
LEISURE FACILITIES—2.1%
               
Planet Fitness, Inc., Cl. A*
   
394,067
     
28,372,824
 
LIFE SCIENCES TOOLS & SERVICES—2.7%
               
NeoGenomics, Inc.*
   
693,787
     
36,784,587
 
MANAGED HEALTHCARE—6.0%
               
Progyny, Inc.*
   
1,727,031
     
80,773,240
 
OIL & GAS EQUIPMENT & SERVICES—3.0%
               
Core Laboratories NV
   
1,219,137
     
40,207,138
 
PHARMACEUTICALS—0.4%
               
Aerie Pharmaceuticals, Inc.*
   
285,179
     
4,902,227
 
REAL ESTATE SERVICES—5.4%
               
FirstService Corp.
   
526,867
     
72,101,749
 
REGIONAL BANKS—3.7%
               
Signature Bank
   
304,377
     
50,280,037
 
RESTAURANTS—0.8%
               
Wingstop, Inc.
   
75,615
     
11,346,031
 
SEMICONDUCTORS—1.0%
               
Impinj, Inc.*
   
244,506
     
12,951,483
 
SYSTEMS SOFTWARE—0.9%
               
Rapid7, Inc.*
   
132,542
     
11,507,296
 
THRIFTS & MORTGAGE FINANCE—0.7%
               
Axos Financial, Inc.*
   
249,571
     
9,720,790
 

- 24 -

THE ALGER FUNDS
 
ALGER WEATHERBIE SPECIALIZED GROWTH FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—98.2% (CONT.)
 
SHARES
   
VALUE
 
TRADING COMPANIES & DISTRIBUTORS—2.5%
           
SiteOne Landscape Supply, Inc.*
   
213,544
   
$
33,671,618
 
TOTAL COMMON STOCKS
               
(Cost $882,251,525)
           
1,322,099,217
 
PREFERRED STOCKS—0.0%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%
               
Prosetta Biosciences, Inc., Series D*,@,(a),(b)
   
231,474
     
34,721
 
(Cost $1,041,633)
           
34,721
 
Total Investments
               
(Cost $883,293,158)
   
98.2
%
 
$
1,322,133,938
 
Affiliated Securities (Cost $1,041,633)
           
34,721
 
Unaffiliated Securities (Cost $882,251,525)
           
1,322,099,217
 
Other Assets in Excess of Liabilities
   
1.8
%
   
24,547,538
 
NET ASSETS
   
100.0
%
 
$
1,346,681,476
 
 
#
American Depositary Receipts.
(a)
Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 5 - Affiliated Securities.
(b)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
*
Non-income producing security.
@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.
 
 
 
Security
 
Acquisition Date(s)
 
Acquisition
Cost
   
% of net assets (Acquisition
Date)
   
Market
Value
   
% of net assets as of
1/31/2021
 
Prosetta Biosciences, Inc., Series D
2/6/15
 
$
1,041,633
     
0.10
%
 
$
34,721
     
0.00
%
Total
                   
$
34,721
     
0.00
%
 
See Notes to Financial Statements.

- 25 -

THE ALGER FUNDS
 
ALGER SMALL CAP GROWTH FUND
Schedule of Investments January 31, 2021 (Unaudited)

COMMON STOCKS—90.5%
 
SHARES
 
 
VALUE
 
AEROSPACE & DEFENSE—0.9%
           
Hexcel Corp.
   
34,217
   
$
1,493,914
 
Mercury Systems, Inc.*
   
54,017
     
3,838,448
 
             
5,332,362
 
AGRICULTURAL & FARM MACHINERY—1.1%
               
Hydrofarm Holdings Group, Inc.*
   
86,644
     
6,542,488
 
ALTERNATIVE CARRIERS—1.1%
               
Bandwidth, Inc., Cl. A*
   
35,135
     
6,258,949
 
APPAREL RETAIL—0.7%
               
Burlington Stores, Inc.*
   
16,007
     
3,984,142
 
APPLICATION SOFTWARE—19.1%
               
ACI Worldwide, Inc.*
   
242,969
     
9,327,580
 
Avalara, Inc.*
   
75,095
     
11,264,250
 
Benefitfocus, Inc.*
   
112,510
     
1,383,873
 
Bill.com Holdings, Inc.*
   
51,055
     
6,222,583
 
Blackbaud, Inc.
   
52,141
     
3,466,855
 
Blackline, Inc.*
   
25,994
     
3,369,342
 
Coupa Software, Inc.*
   
25,361
     
7,858,613
 
Everbridge, Inc.*
   
56,890
     
7,562,388
 
Guidewire Software, Inc.*
   
36,254
     
4,159,784
 
HubSpot, Inc.*
   
33,899
     
12,617,208
 
Manhattan Associates, Inc.*
   
43,520
     
4,927,770
 
Medallia, Inc.*
   
95,176
     
3,949,804
 
Paycom Software, Inc.*
   
20,907
     
7,939,224
 
Q2 Holdings, Inc.*
   
75,077
     
9,609,105
 
Smartsheet, Inc., Cl. A*
   
50,161
     
3,498,228
 
Sprout Social, Inc., Cl. A*
   
46,113
     
3,043,458
 
SPS Commerce, Inc.*
   
42,064
     
4,159,709
 
Tyler Technologies, Inc.*
   
9,415
     
3,980,568
 
Vertex, Inc., Cl. A*
   
102,413
     
3,364,267
 
             
111,704,609
 
ASSET MANAGEMENT & CUSTODY BANKS—0.8%
               
Affiliated Managers Group, Inc.
   
41,772
     
4,602,857
 
BIOTECHNOLOGY—4.4%
               
CareDx, Inc.*
   
219,083
     
16,744,514
 
Exact Sciences Corp.*
   
38,463
     
5,275,585
 
Karuna Therapeutics, Inc.*
   
12,541
     
1,244,443
 
Turning Point Therapeutics, Inc.*
   
19,032
     
2,388,326
 
             
25,652,868
 
CASINOS & GAMING—3.8%
               
DraftKings, Inc., Cl. A*
   
208,643
     
11,289,673
 
Penn National Gaming, Inc.*
   
103,931
     
10,779,723
 
             
22,069,396
 
CONSUMER FINANCE—1.7%
               
dMY Technology Group, Inc. II, Cl. A*
   
482,022
     
10,001,957
 
DIVERSIFIED SUPPORT SERVICES—0.4%
               
IAA, Inc.*
   
41,858
     
2,391,766
 

- 26 -

THE ALGER FUNDS
 
ALGER SMALL CAP GROWTH FUND
Schedule of Investments January 31, 2021 (Unaudited)

COMMON STOCKS—90.5% (CONT.)
 
SHARES
   
VALUE
 
ELECTRICAL COMPONENTS & EQUIPMENT—1.2%
           
Sunrun, Inc.*
   
104,635
   
$
7,248,066
 
ELECTRONIC COMPONENTS—0.6%
               
Dolby Laboratories, Inc., Cl. A
   
39,753
     
3,499,457
 
ELECTRONIC EQUIPMENT & INSTRUMENTS—1.1%
               
Cognex Corp.
   
75,217
     
6,177,572
 
FINANCIAL EXCHANGES & DATA—0.7%
               
Tradeweb Markets, Inc., Cl. A
   
70,763
     
4,301,683
 
FOOD DISTRIBUTORS—1.5%
               
The Chefs' Warehouse, Inc.*
   
77,983
     
2,128,156
 
US Foods Holding Corp.*
   
209,490
     
6,492,095
 
             
8,620,251
 
HEALTHCARE EQUIPMENT—10.3%
               
ABIOMED, Inc.*
   
20,024
     
6,973,358
 
Cantel Medical Corp.*
   
105,180
     
8,306,065
 
CryoPort, Inc.*
   
113,772
     
7,759,251
 
DexCom, Inc.*
   
21,982
     
8,239,953
 
Inmode Ltd.*
   
36,769
     
2,164,223
 
Inogen, Inc.*
   
29,567
     
1,446,713
 
Insulet Corp.*
   
57,157
     
15,271,207
 
Mesa Laboratories, Inc.
   
9,379
     
2,599,296
 
Tandem Diabetes Care, Inc.*
   
78,172
     
7,242,636
 
             
60,002,702
 
HEALTHCARE SERVICES—3.0%
               
1Life Healthcare, Inc.*
   
122,552
     
6,201,131
 
Biodesix, Inc.*
   
61,342
     
1,483,250
 
Guardant Health, Inc.*
   
53,968
     
8,392,024
 
Progenity, Inc.*
   
199,340
     
1,371,459
 
             
17,447,864
 
HEALTHCARE SUPPLIES—4.5%
               
Neogen Corp.*
   
118,549
     
9,587,057
 
Quidel Corp.*
   
67,478
     
16,934,954
 
             
26,522,011
 
HEALTHCARE TECHNOLOGY—6.0%
               
Teladoc Health, Inc.*
   
40,078
     
10,573,779
 
Veeva Systems, Inc., Cl. A*
   
57,667
     
15,941,466
 
Vocera Communications, Inc.*
   
197,535
     
8,681,663
 
             
35,196,908
 
HOMEFURNISHING RETAIL—0.7%
               
Bed Bath & Beyond, Inc.
   
117,097
     
4,137,037
 
HYPERMARKETS & SUPER CENTERS—0.7%
               
BJ's Wholesale Club Holdings, Inc.*
   
98,861
     
4,159,082
 
INSURANCE BROKERS—0.3%
               
eHealth, Inc.*
   
32,817
     
1,570,294
 
INTERACTIVE HOME ENTERTAINMENT—1.0%
               
Take-Two Interactive Software, Inc.*
   
28,345
     
5,681,755
 

- 27 -

THE ALGER FUNDS
 
ALGER SMALL CAP GROWTH FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—90.5% (CONT.)
 
SHARES
   
VALUE
 
INTERACTIVE MEDIA & SERVICES—0.4%
           
Eventbrite, Inc., Cl. A*
   
114,151
   
$
2,037,595
 
INTERNET & DIRECT MARKETING RETAIL—5.3%
               
Farfetch Ltd., Cl. A*
   
168,237
     
10,302,834
 
Fiverr International Ltd.*
   
33,015
     
6,817,927
 
Magnite, Inc.*
   
285,570
     
9,892,145
 
The RealReal, Inc.*
   
159,003
     
3,765,191
 
             
30,778,097
 
INTERNET SERVICES & INFRASTRUCTURE—0.4%
               
BigCommerce Holdings, Inc.*
   
32,008
     
2,558,720
 
LEISURE FACILITIES—0.4%
               
Planet Fitness, Inc., Cl. A*
   
36,264
     
2,611,008
 
LIFE SCIENCES TOOLS & SERVICES—7.8%
               
10X Genomics, Inc., Cl. A*
   
31,518
     
5,394,306
 
Bio-Techne Corp.
   
43,866
     
14,252,502
 
Maravai LifeSciences Holdings, Inc., Cl. A*
   
38,051
     
1,325,697
 
NanoString Technologies, Inc.*
   
158,158
     
11,075,805
 
NeoGenomics, Inc.*
   
90,429
     
4,794,545
 
PRA Health Sciences, Inc.*
   
22,823
     
2,812,706
 
Repligen Corp.*
   
30,514
     
6,102,800
 
             
45,758,361
 
MANAGED HEALTHCARE—0.7%
               
HealthEquity, Inc.*
   
49,095
     
4,101,887
 
MOVIES & ENTERTAINMENT—0.8%
               
Live Nation Entertainment, Inc.*
   
66,988
     
4,451,353
 
OIL & GAS EXPLORATION & PRODUCTION—0.8%
               
Magnolia Oil & Gas Corp., Cl. A*
   
548,040
     
4,641,899
 
PHARMACEUTICALS—0.2%
               
Aerie Pharmaceuticals, Inc.*
   
75,221
     
1,293,049
 
REGIONAL BANKS—0.6%
               
Webster Financial Corp.
   
78,373
     
3,663,938
 
RESTAURANTS—2.8%
               
Shake Shack, Inc., Cl. A*
   
86,594
     
9,821,492
 
Wingstop, Inc.
   
43,100
     
6,467,155
 
             
16,288,647
 
SEMICONDUCTOR EQUIPMENT—0.9%
               
SolarEdge Technologies, Inc.*
   
17,162
     
4,948,320
 
SEMICONDUCTORS—0.9%
               
Universal Display Corp.
   
22,106
     
5,102,507
 
SPECIALTY CHEMICALS—0.8%
               
Balchem Corp.
   
42,173
     
4,513,776
 
SPECIALTY STORES—1.1%
               
Five Below, Inc.*
   
27,426
     
4,819,571
 
Leslie's, Inc.*
   
6,810
     
194,766
 
Sportsman's Warehouse Holdings, Inc.*
   
84,137
     
1,474,080
 
             
6,488,417
 

- 28 -

THE ALGER FUNDS
 
ALGER SMALL CAP GROWTH FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—90.5% (CONT.)
 
SHARES
   
VALUE
 
SYSTEMS SOFTWARE—1.0%
           
Proofpoint, Inc.*
   
46,305
   
$
5,977,049
 
TOTAL COMMON STOCKS
               
(Cost $310,353,623)
           
528,320,699
 
PREFERRED STOCKS—0.0%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%
               
Prosetta Biosciences, Inc., Series D*,@,(a),(b)
   
50,688
     
7,603
 
(Cost $228,096)
           
7,603
 
RIGHTS—0.0%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%
               
Tolero CDR*,@,(a),(c)
   
174,782
     
120,600
 
(Cost $94,483)
           
120,600
 
REAL ESTATE INVESTMENT TRUST—1.1%
 
SHARES
   
VALUE
 
SPECIALIZED—1.1%
               
Digital Realty Trust, Inc.
   
45,352
     
6,528,420
 
(Cost $5,951,480)
           
6,528,420
 
SPECIAL PURPOSE VEHICLE—0.4%
 
SHARES
   
VALUE
 
DATA PROCESSING & OUTSOURCED SERVICES—0.4%
               
Crosslink Ventures Capital LLC, Cl. A*,@,(a),(b)
   
72
     
1,800,000
 
Crosslink Ventures Capital LLC, Cl. B*,@,(a),(b)
   
19
     
475,000
 
             
2,275,000
 
TOTAL SPECIAL PURPOSE VEHICLE
               
(Cost $2,275,000)
           
2,275,000
 
Total Investments
               
(Cost $318,902,682)
   
92.0
%
 
$
537,252,322
 
Affiliated Securities (Cost $2,503,096)
           
2,282,603
 
Unaffiliated Securities (Cost $316,399,586)
           
534,969,719
 
Other Assets in Excess of Liabilities
   
8.0
%
   
46,984,396
 
NET ASSETS
   
100.0
%
 
$
584,236,718
 
 
(a)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(b)
Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 5 - Affiliated Securities.
(c)
Contingent Deferred Rights.
*
Non-income producing security.
@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.
 
 
 
Security
 
Acquisition Date(s)
 
Acquisition
Cost
   
% of net assets (Acquisition
Date)
   
Market
Value
   
% of net assets as of
1/31/2021
 
Crosslink Ventures Capital LLC, Cl. A
10/2/20
 
$
1,800,000
     
0.49
%
 
$
1,800,000
     
0.31
%
Crosslink Ventures Capital LLC, Cl. B
12/16/20
   
475,000
     
0.10
%
   
475,000
     
0.08
%
Prosetta Biosciences, Inc., Series D
2/6/15
   
228,096
     
0.10
%
   
7,603
     
0.00
%
Tolero CDR
2/6/17
   
94,483
     
0.08
%
   
120,600
     
0.02
%
Total
                   
$
2,403,203
     
0.41
%
 
See Notes to Financial Statements.

- 29 -

THE ALGER FUNDS
 
ALGER SMALL CAP FOCUS FUND
Schedule of Investments January 31, 2021 (Unaudited)

COMMON STOCKS—97.8%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—1.0%
           
Mercury Systems, Inc.*
   
1,170,390
   
$
83,167,913
 
ALTERNATIVE CARRIERS—1.3%
               
Bandwidth, Inc., Cl. A*
   
566,582
     
100,930,918
 
APPLICATION SOFTWARE—22.1%
               
ANSYS, Inc.*
   
445,432
     
157,847,738
 
Avalara, Inc.*
   
1,159,410
     
173,911,500
 
Blackline, Inc.*
   
1,360,409
     
176,336,215
 
Coupa Software, Inc.*
   
451,704
     
139,969,518
 
Datadog, Inc., Cl. A*
   
1,405,201
     
144,384,403
 
Everbridge, Inc.*
   
1,101,915
     
146,477,561
 
Guidewire Software, Inc.*
   
1,006,464
     
115,481,679
 
Medallia, Inc.*
   
1,817,677
     
75,433,595
 
Model N, Inc.*
   
3,107,542
     
105,594,277
 
Paycom Software, Inc.*
   
336,925
     
127,943,900
 
PROS Holdings, Inc.*
   
2,065,118
     
87,024,073
 
Q2 Holdings, Inc.*
   
989,802
     
126,684,758
 
Smartsheet, Inc., Cl. A*
   
1,156,833
     
80,677,533
 
Tyler Technologies, Inc.*
   
266,038
     
112,478,206
 
             
1,770,244,956
 
BIOTECHNOLOGY—10.0%
               
CareDx, Inc.*
   
4,197,582
     
320,821,192
 
Natera, Inc.*
   
3,849,750
     
410,537,340
 
Vericel Corp.*
   
1,662,472
     
68,610,220
 
             
799,968,752
 
BUILDING PRODUCTS—2.2%
               
Trex Co., Inc.*
   
1,888,109
     
173,271,763
 
EDUCATION SERVICES—3.2%
               
Chegg, Inc.*
   
2,693,974
     
256,627,963
 
ELECTRONIC EQUIPMENT & INSTRUMENTS—2.2%
 
Cognex Corp.
   
2,162,268
     
177,587,071
 
HEALTHCARE DISTRIBUTORS—0.8%
               
PetIQ, Inc., Cl. A*
   
1,860,698
     
64,491,793
 
HEALTHCARE EQUIPMENT—18.2%
               
AtriCure, Inc.*
   
2,881,152
     
167,769,481
 
Cantel Medical Corp.*
   
2,506,023
     
197,900,636
 
CryoPort, Inc.*
   
4,676,882
     
318,963,352
 
Heska Corp.*
   
1,025,158
     
171,570,443
 
Insulet Corp.*
   
668,080
     
178,497,614
 
iRhythm Technologies, Inc.*
   
332,613
     
56,018,682
 
Nevro Corp.*
   
954,833
     
154,482,431
 
Shockwave Medical, Inc.*
   
923,512
     
107,164,333
 
Tactile Systems Technology, Inc.*
   
1,903,368
     
103,828,724
 
             
1,456,195,696
 
HEALTHCARE SERVICES—2.3%
               
Guardant Health, Inc.*
   
1,160,083
     
180,392,907
 

- 30 -

THE ALGER FUNDS
 
ALGER SMALL CAP FOCUS FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—97.8% (CONT.)
 
SHARES
   
VALUE
 
HEALTHCARE SUPPLIES—4.8%
           
Neogen Corp.*
   
1,531,679
   
$
123,866,881
 
Quidel Corp.*
   
1,035,340
     
259,839,280
 
             
383,706,161
 
HEALTHCARE TECHNOLOGY—4.3%
               
Inspire Medical Systems, Inc.*
   
655,118
     
132,012,828
 
Veeva Systems, Inc., Cl. A*
   
760,935
     
210,352,872
 
             
342,365,700
 
INDUSTRIAL MACHINERY—1.7%
               
RBC Bearings, Inc.*
   
819,774
     
137,172,783
 
INTERNET & DIRECT MARKETING RETAIL—1.1%
               
Stamps.com, Inc.*
   
388,937
     
88,798,206
 
INTERNET SERVICES & INFRASTRUCTURE—1.1%
               
BigCommerce Holdings, Inc.*
   
1,097,864
     
87,763,248
 
LIFE SCIENCES TOOLS & SERVICES—8.5%
               
Berkeley Lights, Inc.*
   
1,902,983
     
137,014,776
 
Bio-Techne Corp.
   
540,332
     
175,559,270
 
NanoString Technologies, Inc.*
   
1,966,945
     
137,745,158
 
Repligen Corp.*
   
1,126,596
     
225,319,200
 
             
675,638,404
 
MANAGED HEALTHCARE—1.3%
               
HealthEquity, Inc.*
   
1,243,306
     
103,878,216
 
RESTAURANTS—4.8%
               
Shake Shack, Inc., Cl. A*
   
1,739,863
     
197,335,261
 
Wingstop, Inc.
   
1,246,810
     
187,083,841
 
             
384,419,102
 
SEMICONDUCTORS—2.7%
               
Monolithic Power Systems, Inc.
   
618,227
     
219,649,871
 
SYSTEMS SOFTWARE—4.2%
               
Appian Corp., Cl. A*
   
1,002,135
     
218,926,412
 
Sailpoint Technologies Holdings, Inc.*
   
2,052,903
     
113,546,065
 
             
332,472,477
 
TOTAL COMMON STOCKS
               
(Cost $4,600,379,482)
           
7,818,743,900
 
RIGHTS—0.0%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%
               
Tolero CDR*,@,(a),(b)
   
11,905
     
8,214
 
(Cost $6,436)
           
8,214
 
Total Investments
               
(Cost $4,600,385,918)
   
97.8
%
 
$
7,818,752,114
 
Unaffiliated Securities (Cost $4,600,385,918)
           
7,818,752,114
 
Other Assets in Excess of Liabilities
   
2.2
%
   
178,617,219
 
NET ASSETS
   
100.0
%
 
$
7,997,369,333
 

(a)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(b)
Contingent Deferred Rights.
*
Non-income producing security.
@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.

- 31 -

THE ALGER FUNDS
 
ALGER SMALL CAP FOCUS FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)
 
 
 
Security
 
Acquisition Date(s)
 
Acquisition
Cost
   
% of net assets (Acquisition
Date)
   
Market
Value
   
% of net assets as of
1/31/2021
 
Tolero CDR
2/6/17
 
$
6,436
     
0.00
%
 
$
8,214
     
0.00
%
Total
                   
$
8,214
     
0.00
%

See Notes to Financial Statements.

- 32 -

THE ALGER FUNDS
 
ALGER INTERNATIONAL FOCUS FUND
Schedule of Investments January 31, 2021 (Unaudited)

COMMON STOCKS—97.3%
 
SHARES
   
VALUE
 
AUSTRALIA—6.1%
           
APPLICATION SOFTWARE—2.4%
           
Xero Ltd.*
   
46,600
   
$
4,596,730
 
HEALTHCARE SUPPLIES—1.3%
               
Nanosonics Ltd.*
   
490,062
     
2,543,109
 
INTERNET & DIRECT MARKETING RETAIL—2.4%
               
Kogan.com Ltd.
   
347,253
     
4,740,055
 
TOTAL AUSTRALIA
               
(Cost $6,297,886)
           
11,879,894
 
BELGIUM—1.5%
               
APPLICATION SOFTWARE—1.5%
               
Unifiedpost Group SA*
   
112,287
     
2,888,599
 
(Cost $2,879,104)
               
BRAZIL—1.7%
               
DIVERSIFIED CAPITAL MARKETS—1.7%
               
Banco BTG Pactual SA
   
191,000
     
3,318,021
 
(Cost $3,435,223)
               
CHINA—12.5%
               
AUTOMOBILE MANUFACTURERS—2.6%
               
Geely Automobile Holdings Ltd.
   
1,399,000
     
5,071,114
 
CONSTRUCTION MACHINERY & HEAVY TRUCKS—2.0%
               
Sany Heavy Industry Co., Ltd., Cl. A
   
634,843
     
3,966,209
 
INTERACTIVE MEDIA & SERVICES—2.4%
               
Tencent Holdings Ltd.
   
52,800
     
4,704,685
 
INTERNET & DIRECT MARKETING RETAIL—4.1%
               
JD.com, Inc.#,*
   
40,200
     
3,565,338
 
Meituan, Cl. B*
   
94,000
     
4,334,312
 
             
7,899,650
 
SEMICONDUCTORS—1.4%
               
LONGi Green Energy Technology Co., Ltd., Cl. A
   
165,689
     
2,748,040
 
TOTAL CHINA
               
(Cost $14,777,349)
           
24,389,698
 
FRANCE—9.5%
               
AEROSPACE & DEFENSE—1.9%
               
Airbus SE*
   
36,400
     
3,659,999
 
APPAREL ACCESSORIES & LUXURY GOODS—2.7%
               
LVMH Moet Hennessy Louis Vuitton SE
   
8,700
     
5,259,547
 
LIFE SCIENCES TOOLS & SERVICES—2.8%
               
Eurofins Scientific SE*
   
57,500
     
5,518,787
 
RESEARCH & CONSULTING SERVICES—2.1%
               
Teleperformance
   
12,557
     
4,106,832
 
TOTAL FRANCE
               
(Cost $10,873,163)
           
18,545,165
 
GERMANY—3.5%
               
FOOTWEAR—1.8%
               
Puma SE*
   
35,300
     
3,453,938
 

- 33 -

THE ALGER FUNDS
 
ALGER INTERNATIONAL FOCUS FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—97.3% (CONT.)
 
SHARES
   
VALUE
 
GERMANY—3.5% (CONT.)
           
OIL & GAS REFINING & MARKETING—1.7%
           
VERBIO Vereinigte BioEnergie AG
   
65,508
   
$
3,317,835
 
TOTAL GERMANY
               
(Cost $5,114,410)
           
6,771,773
 
HONG KONG—5.8%
               
APPAREL ACCESSORIES & LUXURY GOODS—1.8%
               
Samsonite International SA*
   
2,401,820
     
3,453,644
 
FINANCIAL EXCHANGES & DATA—2.2%
               
Hong Kong Exchanges & Clearing Ltd.
   
66,500
     
4,251,520
 
INDUSTRIAL MACHINERY—1.8%
               
Techtronic Industries Co., Ltd.
   
237,000
     
3,540,419
 
TOTAL HONG KONG
               
(Cost $6,321,397)
           
11,245,583
 
HUNGARY—1.6%
               
AIRLINES—1.6%
               
Wizz Air Holdings PLC*
   
54,000
     
3,222,132
 
(Cost $3,354,071)
               
INDIA—2.5%
               
DIVERSIFIED BANKS—2.5%
               
HDFC Bank Ltd.#,*
   
66,800
     
4,816,280
 
(Cost $2,835,776)
               
IRELAND—2.3%
               
PACKAGED FOODS & MEATS—2.3%
               
Kerry Group PLC, Cl. A
   
33,741
     
4,578,517
 
(Cost $3,756,243)
               
ITALY—5.9%
               
APPAREL ACCESSORIES & LUXURY GOODS—2.1%
               
Moncler SpA*
   
70,986
     
3,999,887
 
AUTOMOBILE MANUFACTURERS—2.2%
               
Ferrari NV
   
21,062
     
4,384,687
 
DATA PROCESSING & OUTSOURCED SERVICES—1.6%
 
Nexi SpA*
   
177,900
     
3,155,890
 
TOTAL ITALY
               
(Cost $7,699,318)
           
11,540,464
 
JAPAN—11.3%
               
ELECTRONIC COMPONENTS—3.0%
               
Murata Manufacturing Co., Ltd.
   
61,400
     
5,897,069
 
HEALTHCARE SUPPLIES—1.8%
               
Hoya Corp.
   
27,900
     
3,569,743
 
INDUSTRIAL MACHINERY—2.9%
               
FANUC Corp.
   
21,600
     
5,638,827
 
INTERACTIVE HOME ENTERTAINMENT—1.4%
               
Nintendo Co., Ltd.
   
4,700
     
2,705,357
 

- 34 -

THE ALGER FUNDS
 
ALGER INTERNATIONAL FOCUS FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—97.3% (CONT.)
 
SHARES
   
VALUE
 
JAPAN—11.3% (CONT.)
           
SEMICONDUCTOR EQUIPMENT—2.2%
           
Lasertec Corp.
   
31,599
   
$
4,232,421
 
TOTAL JAPAN
               
(Cost $12,424,570)
           
22,043,417
 
NETHERLANDS—9.5%
               
AIR FREIGHT & LOGISTICS—1.7%
               
InPost SA*
   
134,623
     
3,234,494
 
DATA PROCESSING & OUTSOURCED SERVICES—2.3%
 
Adyen NV*
   
2,100
     
4,386,594
 
HEAVY ELECTRICAL EQUIPMENT—2.4%
               
Alfen Beheer BV*
   
48,600
     
4,759,878
 
SEMICONDUCTOR EQUIPMENT—3.1%
               
ASML Holding NV
   
11,500
     
6,138,815
 
TOTAL NETHERLANDS
               
(Cost $8,519,327)
           
18,519,781
 
SOUTH KOREA—3.9%
               
SPECIALTY CHEMICALS—1.2%
               
Chunbo Co., Ltd.
   
14,000
     
2,282,969
 
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—2.7%
 
Samsung Electronics Co., Ltd.
   
72,500
     
5,301,278
 
TOTAL SOUTH KOREA
               
(Cost $7,006,720)
           
7,584,247
 
SPAIN—2.8%
               
BIOTECHNOLOGY—1.7%
               
Grifols SA#
   
192,941
     
3,411,197
 
ELECTRICAL COMPONENTS & EQUIPMENT—1.1%
               
Soltec Power Holdings SA*
   
167,007
     
2,131,927
 
TOTAL SPAIN
               
(Cost $6,114,978)
           
5,543,124
 
SWEDEN—4.6%
               
ASSET MANAGEMENT & CUSTODY BANKS—2.6%
               
EQT AB
   
162,898
     
5,076,888
 
INTERACTIVE HOME ENTERTAINMENT—2.0%
               
Stillfront Group AB*
   
363,370
     
3,854,300
 
TOTAL SWEDEN
               
(Cost $4,664,261)
           
8,931,188
 
SWITZERLAND—4.1%
               
ASSET MANAGEMENT & CUSTODY BANKS—1.8%
               
Partners Group Holding AG
   
2,934
     
3,464,249
 
SPECIALTY CHEMICALS—2.3%
               
Sika AG
   
16,700
     
4,544,013
 
TOTAL SWITZERLAND
               
(Cost $4,414,931)
           
8,008,262
 

- 35 -

THE ALGER FUNDS
 
ALGER INTERNATIONAL FOCUS FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—97.3% (CONT.)
 
SHARES
   
VALUE
 
TAIWAN—2.9%
           
SEMICONDUCTORS—2.9%
Taiwan Semiconductor Manufacturing Co., Ltd.#
   
46,700
   
$
5,674,984
 
(Cost $4,053,866)
               
UNITED KINGDOM—2.1%
               
FINANCIAL EXCHANGES & DATA—2.1%
London Stock Exchange Group PLC
   
35,200
     
4,178,771
 
(Cost $2,665,698)
               
UNITED STATES—3.2%
               
APPAREL ACCESSORIES & LUXURY GOODS—2.0%
               
Lululemon Athletica, Inc.*
    11,891
      3,908,334  
OTHER DIVERSIFIED FINANCIAL SERVICES—1.2%
Vinci Partners Investments Ltd., Cl. A*
   
139,335
     
2,375,662
 
TOTAL UNITED STATES
(Cost $4,718,921)
           
6,283,996
 
TOTAL COMMON STOCKS
(Cost $121,927,212)
           
189,963,896
 
Total Investments
(Cost $121,927,212)
   
97.3
%
 
$
189,963,896
 
Unaffiliated Securities (Cost $121,927,212)
           
189,963,896
 
Other Assets in Excess of Liabilities
   
2.7
%
   
5,236,173
 
NET ASSETS
   
100.0
%
 
$
195,200,069
 

#
American Depositary Receipts.
*
Non-income producing security.

See Notes to Financial Statements.

- 36 -

THE ALGER FUNDS
 
ALGER HEALTH SCIENCES FUND
Schedule of Investments January 31, 2021 (Unaudited)

COMMON STOCKS—97.5%
 
SHARES
   
VALUE
 
APPLICATION SOFTWARE—1.0%
           
Benefitfocus, Inc.*
   
245,565
   
$
3,020,450
 
BIOTECHNOLOGY—27.1%
               
AbbVie, Inc.
   
86,955
     
8,911,148
 
ACADIA Pharmaceuticals, Inc.*
   
25,375
     
1,219,269
 
Apellis Pharmaceuticals, Inc.*
   
14,596
     
646,165
 
Argenx SE#,*
   
5,887
     
1,725,009
 
Arrowhead Pharmaceuticals, Inc.*
   
34,809
     
2,686,211
 
Aurinia Pharmaceuticals, Inc.*
   
222,048
     
3,710,422
 
BeiGene Ltd.#,*
   
4,231
     
1,353,920
 
Biogen, Inc.*
   
17,725
     
5,009,262
 
Biohaven Pharmaceutical Holding Co., Ltd.*
   
8,756
     
746,186
 
BioMarin Pharmaceutical, Inc.*
   
38,951
     
3,224,364
 
ChemoCentryx, Inc.*
   
22,898
     
1,305,415
 
Denali Therapeutics, Inc.*
   
16,634
     
1,139,429
 
Exact Sciences Corp.*
   
31,927
     
4,379,107
 
Fate Therapeutics, Inc.*
   
11,277
     
1,022,035
 
Forte Biosciences, Inc.*
   
218,204
     
7,388,387
 
Halozyme Therapeutics, Inc.*
   
69,352
     
3,300,462
 
Incyte Corp.*
   
17,359
     
1,557,970
 
Intellia Therapeutics, Inc.*
   
20,873
     
1,307,067
 
Invitae Corp.*
   
95,423
     
4,725,347
 
Iovance Biotherapeutics, Inc.*
   
18,549
     
813,188
 
Kadmon Holdings, Inc.*
   
177,220
     
850,656
 
Karuna Therapeutics, Inc.*
   
14,251
     
1,414,127
 
Mirati Therapeutics, Inc.*
   
7,667
     
1,574,265
 
Natera, Inc.*
   
69,701
     
7,432,915
 
Rocket Pharmaceuticals, Inc.*
   
12,495
     
688,225
 
Sage Therapeutics, Inc.*
   
21,814
     
1,759,299
 
Scholar Rock Holding Corp.*
   
29,820
     
1,779,061
 
Seagen, Inc.*
   
13,296
     
2,184,134
 
TCR2 Therapeutics, Inc.*
   
92,742
     
2,386,252
 
TG Therapeutics, Inc.*
   
75,303
     
3,634,876
 
Turning Point Therapeutics, Inc.*
   
23,907
     
3,000,089
 
Vertex Pharmaceuticals, Inc.*
   
12,804
     
2,933,140
 
             
85,807,402
 
HEALTHCARE EQUIPMENT—24.2%
               
Abbott Laboratories
   
56,232
     
6,949,713
 
ABIOMED, Inc.*
   
10,957
     
3,815,775
 
Boston Scientific Corp.*
   
55,636
     
1,971,740
 
CryoPort, Inc.*
   
60,956
     
4,157,199
 
Danaher Corp.
   
37,243
     
8,857,875
 
DexCom, Inc.*
   
23,486
     
8,803,727
 
Edwards Lifesciences Corp.*
   
41,292
     
3,409,893
 
IDEXX Laboratories, Inc.*
   
19,183
     
9,182,518
 
Insulet Corp.*
   
29,716
     
7,939,521
 
Intuitive Surgical, Inc.*
   
5,781
     
4,322,107
 
iRhythm Technologies, Inc.*
   
8,463
     
1,425,339
 
Masimo Corp.*
   
17,282
     
4,422,809
 

- 37 -

THE ALGER FUNDS
 
ALGER HEALTH SCIENCES FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—97.5% (CONT.)
 
SHARES
   
VALUE
 
HEALTHCARE EQUIPMENT—24.2% (CONT.)
           
Nevro Corp.*
   
28,731
   
$
4,648,389
 
Sartorius AG
   
9,983
     
4,962,102
 
Tandem Diabetes Care, Inc.*
   
16,965
     
1,571,807
 
             
76,440,514
 
HEALTHCARE SERVICES—4.4%
               
1Life Healthcare, Inc.*
   
67,121
     
3,396,322
 
Cigna Corp.
   
9,637
     
2,091,711
 
Guardant Health, Inc.*
   
53,316
     
8,290,638
 
             
13,778,671
 
HEALTHCARE SUPPLIES—3.5%
               
Quidel Corp.*
   
19,613
     
4,922,275
 
STAAR Surgical Co.*
   
31,306
     
3,211,369
 
West Pharmaceutical Services, Inc.
   
9,553
     
2,861,028
 
             
10,994,672
 
HEALTHCARE TECHNOLOGY—6.2%
               
Phreesia, Inc.*
   
16,070
     
1,049,210
 
Schrodinger, Inc.*
   
22,953
     
2,073,344
 
Tabula Rasa HealthCare, Inc.*
   
46,387
     
2,634,318
 
Teladoc Health, Inc.*
   
23,767
     
6,270,448
 
Veeva Systems, Inc., Cl. A*
   
27,719
     
7,662,640
 
             
19,689,960
 
INSURANCE BROKERS—0.3%
               
eHealth, Inc.*
   
22,366
     
1,070,213
 
LIFE SCIENCES TOOLS & SERVICES—11.0%
               
10X Genomics, Inc., Cl. A*
   
26,554
     
4,544,717
 
Adaptive Biotechnologies Corp.*
   
26,105
     
1,448,044
 
Berkeley Lights, Inc.*
   
11,150
     
802,800
 
Bio-Techne Corp.
   
24,100
     
7,830,331
 
Illumina, Inc.*
   
6,785
     
2,893,396
 
NeoGenomics, Inc.*
   
29,633
     
1,571,142
 
Personalis, Inc.*
   
137,419
     
5,286,509
 
Quanterix Corp.*
   
25,300
     
1,637,922
 
Repligen Corp.*
   
27,038
     
5,407,600
 
Thermo Fisher Scientific, Inc.
   
6,272
     
3,196,838
 
             
34,619,299
 
MANAGED HEALTHCARE—8.6%
               
Humana, Inc.
   
13,306
     
5,097,661
 
Progyny, Inc.*
   
70,197
     
3,283,114
 
UnitedHealth Group, Inc.
   
56,734
     
18,925,328
 
             
27,306,103
 
PHARMACEUTICALS—11.2%
               
Arvinas, Inc.*
   
9,854
     
743,386
 
AstraZeneca PLC#
   
21,987
     
1,112,542
 
Catalent, Inc.*
   
28,822
     
3,315,971
 
Eli Lilly & Co.
   
56,745
     
11,801,258
 
Horizon Therapeutics PLC*
   
29,529
     
2,140,262
 

- 38 -

THE ALGER FUNDS
 
ALGER HEALTH SCIENCES FUND
Schedule of Investments January 31, 2021 (Unaudited) (Continued)

COMMON STOCKS—97.5% (CONT.)
 
SHARES
   
VALUE
 
PHARMACEUTICALS—11.2% (CONT.)
           
Johnson & Johnson
   
39,964
   
$
6,519,327
 
Ocular Therapeutix, Inc.*
   
70,477
     
1,279,158
 
Reata Pharmaceuticals, Inc., Cl. A*
   
7,912
     
819,604
 
Royalty Pharma PLC, Cl. A
   
28,300
     
1,330,383
 
Viatris, Inc.*
   
123,800
     
2,103,362
 
Zoetis, Inc., Cl. A
   
28,532
     
4,401,061
 
             
35,566,314
 
TOTAL COMMON STOCKS
               
(Cost $228,170,679)
           
308,293,598
 
PREFERRED STOCKS—0.1%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.1%
               
Prosetta Biosciences, Inc., Series D*,@,(a),(b)
   
897,366
     
134,605
 
(Cost $4,038,147)
           
134,605
 
WARRANTS—1.6%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—1.6%
               
Forte Biosciences, Inc., 2/20/21*,@
   
211,625
     
4,930,016
 
(Cost $0)
           
4,930,016
 
RIGHTS—0.4%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.4%
               
Tolero CDR*,@,(a),(c)
   
1,956,996
     
1,350,327
 
(Cost $1,044,370)
           
1,350,327
 
Total Investments
               
(Cost $233,253,196)
   
99.6
%
 
$
314,708,546
 
Affiliated Securities (Cost $4,038,147)
           
134,605
 
Unaffiliated Securities (Cost $229,215,049)
           
314,573,941
 
Other Assets in Excess of Liabilities
   
0.4
%
   
1,393,449
 
NET ASSETS
   
100.0
%
 
$
316,101,995
 
 
#
American Depositary Receipts.
(a)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(b)
Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 5 - Affiliated Securities.
(c)
Contingent Deferred Rights.
*
Non-income producing security.
@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.
 
 
 
Security
 
Acquisition Date(s)
 
Acquisition
Cost
   
% of net assets (Acquisition
Date)
   
Market
Value
   
% of net assets as of
1/31/2021
 
Forte Biosciences, Inc. Warrants
2/19/20
 
$
0
     
0.00
%
 
$
4,930,016
     
1.55
%
Prosetta Biosciences, Inc., Series D
2/6/15
   
4,038,147
     
2.00
%
   
134,605
     
0.05
%
Tolero CDR
2/6/17
   
1,044,370
     
0.90
%
   
1,350,327
     
0.43
%
Total
                   
$
6,414,948
     
2.03
%

See Notes to Financial Statements.

- 39 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited)
 
NOTE 1 — General:

 
The Alger Funds (the “Trust”) is an open-end registered investment company organized as a business trust under the laws of the Commonwealth of Massachusetts. The Trust qualifies as an investment company as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 946-Financial Services – Investment Companies. The Trust operates as a series company currently offering an unlimited number of shares of beneficial interest in eleven series — Alger Capital Appreciation Fund, Alger 25 Fund, Alger 35 Fund, Alger Growth & Income Fund, Alger Mid Cap Growth Fund, Alger Mid Cap Focus Fund, Alger Weatherbie Specialized Growth Fund, Alger Small Cap Growth Fund, Alger Small Cap Focus Fund, Alger International Focus Fund and Alger Health Sciences Fund (collectively, the “Funds” or individually, each a “Fund”). Alger Capital Appreciation Fund, Alger 25 Fund, Alger 35 Fund, Alger Mid Cap Growth Fund, Alger Mid Cap Focus Fund, Alger Weatherbie Specialized Growth Fund, Alger Small Cap Growth Fund, Alger Small Cap Focus Fund, Alger International Focus Fund and Alger Health Sciences Fund normally invest primarily in equity securities and each has an investment objective of long- term capital appreciation. Alger Growth & Income Fund also normally invests primarily in equity securities but has an investment objective of both capital appreciation and current income.
 
Each Fund offers one or more of the following share classes: Class A, B, C, I, P, P-2, Y and Z. Class A shares are generally subject to an initial sales charge while Class B and C shares are generally subject to a deferred sales charge. Class B shares will automatically convert to Class A shares eight years after the end of the calendar month in which the order to purchase was accepted. The conversion is completed without the imposition of any sales charges or other fees. Class C shares will automatically convert to Class A shares on the fifth business day of the month following the tenth anniversary of the purchase date of a shareholder’s Class C shares, without the imposition of any sales load, fee or other charge. Class C shares held at certain dealers may not convert to Class A shares or may be converted on a different schedule. At conversion, a proportionate amount of shares representing reinvested dividends and distributions will also be converted into Class A shares. Effective August 27, 2019, Class C shares were closed to direct shareholders and are only available for purchase through certain financial intermediaries and group retirement plan recordkeeping platforms. Class I, P, P-2, Y and Z shares are sold to investors without an initial or deferred sales charge. Each class has identical rights to assets and earnings, except that each share class bears the pro rata allocation of the Fund’s expenses other than a class expense (not including advisory or custodial fees or other expenses related to the management of the Fund’s assets).
 
The Board of Trustees of the Trust (the "Board") has authorized a partial closing of the Alger Small Cap Focus Fund effective July 31, 2019. Class A, C, I and Z shares will be available for purchase by existing shareholders who maintain open accounts and new investors that utilize certain retirement record keeping platforms identified by Fred Alger & Company, LLC, the Fund’s distributor. Class I and Z shares will also be available for purchase by investors who transact with certain brokers identified by the distributor. Class Y shares will remain open to all qualifying investors.
 
- 40 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
NOTE 2Significant Accounting Policies:

(a) Investment Valuation: The Funds value their financial instruments at fair value using independent dealers or pricing services under policies approved by the Board. Investments held by the Funds are valued on each day the New York Stock Exchange (the “NYSE”) is open, as of the close of the NYSE (normally 4:00 p.m. Eastern Time).
 
Investments in money market funds and short-term securities held by the Funds having a remaining maturity of sixty days or less are valued at amortized cost which approximates market value.
 
Equity securities, including traded rights, warrants and option contracts for which valuation information is readily available, are valued at the last quoted sales price or official closing price on the primary market or exchange on which they are traded as reported by an independent pricing service. In the absence of quoted sales, such securities are valued at the bid price or, in the absence of a recent bid price, the equivalent as obtained from one or more of the major market makers for the securities to be valued.
 
Debt securities generally trade in the over-the-counter market. Debt securities with remaining maturities of more than sixty days at the time of acquisition are valued on the basis of the last available bid prices or current market quotations provided by dealers or pricing services. In determining the value of a particular investment, pricing services may use certain information with respect to transactions in such investments, quotations from dealers, pricing matrixes, market transactions in comparable investments, various relationships observed in the market between investments and calculated yield measures based on valuation technology commonly employed in the market for such investments. Asset-backed and mortgage-backed securities are valued by independent pricing services using models that consider estimated cash flows of each tranche of the security, establish a benchmark yield and develop an estimated tranche-specific spread to the benchmark yield based on the unique attributes of the tranche. Debt securities with a remaining maturity of sixty days or less are valued at amortized cost which approximates market value.
 
Securities for which market quotations are not readily available are valued at fair value, as determined in good faith pursuant to procedures established by the Board and described further herein.
 
Securities in which the Funds invest may be traded in foreign markets that close before the close of the NYSE. Developments that occur between the close of the foreign markets and the close of the NYSE may result in adjustments to the closing foreign prices to reflect what the Trust’s investment adviser, pursuant to policies established by the Board, believes to be the fair value of these securities as of the close of the NYSE. The Funds may also fair value securities in other situations, for example, when a particular foreign market is closed but the Funds are open.

- 41 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

FASB Accounting Standards Codification 820 – Fair Value Measurements and Disclosures (“ASC 820”) defines fair value as the price that the Funds would receive upon selling an investment in a timely transaction to an independent buyer in the principal or most advantageous market of the investment. ASC 820 established a three-tier hierarchy to maximize the use of observable market data and minimize the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability and may be observable or unobservable. Observable inputs are based on market data obtained from sources independent of the Funds. Unobservable inputs are inputs that reflect the Funds’ own assumptions based on the best information available in the circumstances. The three-tier hierarchy of inputs is summarized in the three broad Levels listed below.
 

Level 1 – quoted prices in active markets for identical investments
 

Level 2 – significant other observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)


Level 3 – significant unobservable inputs (including the Funds’ own assumptions in determining the fair value of investments)
 
The Funds’ valuation techniques are generally consistent with either the market or the income approach to fair value. The market approach considers prices and other relevant information generated by market transactions involving identical or comparable assets to measure fair value. The income approach converts future amounts to a current, or discounted, single amount. These fair value measurements are determined on the basis of the value indicated by current market expectations about such future events. Inputs for Level 1 include exchange-listed prices and broker quotes in an active market. Inputs for Level 2 include the last trade price in the case of a halted security, an exchange-listed price which has been adjusted for fair value factors, and prices of closely related securities. Additional Level 2 inputs include an evaluated price which is based upon a compilation of observable market information such as spreads for fixed income and preferred securities. Inputs for Level 3 include, but are not limited to, revenue multiples, earnings before interest, taxes, depreciation and amortization (“EBITDA”) multiples, discount rates, time to exit and the probabilities of success of certain outcomes. Such unobservable market information may be obtained from a company’s financial statements and from industry studies, market data, and market indicators such as benchmarks and indexes. Because of the inherent uncertainty and often limited markets for restricted securities, the valuations assigned to such securities by the Funds may significantly differ from the valuations that would have been assigned by the Funds had there been an active market for such securities.
 
Valuation processes are determined by a Valuation Committee (“Committee”) authorized by the Board and comprised of representatives of the Trust’s investment adviser and officers of the Trust. The Committee reports its fair valuation determinations and related valuation information to the Board. The Board is responsible for approving the valuation policy and procedures.

- 42 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

While the Committee meets on an as-needed basis, the Committee generally meets quarterly to review and evaluate the effectiveness of the procedures for making fair value determinations. The Committee considers, among other things, the results of quarterly back testing of the fair value model for foreign securities, pricing comparisons between primary and secondary price sources, the outcome of price challenges put to the Funds’ pricing vendor, and variances between transactional prices and the previous day’s price.
 
(b)
Cash and Cash Equivalents: Cash and cash equivalents include U.S. dollars, foreign cash
 
and overnight time deposits.
 
NOTE 3 — Fair Value Measurements:

 
The following is a summary of the inputs used as of January 31, 2021 in valuing the Funds’ investments carried at fair value on a recurring basis. Based upon the nature, characteristics, and risks associated with their investments, the Funds have determined that presenting them by security type and sector is appropriate.
 
Alger Capital Appreciation Fund
TOTAL
 
LEVEL 1
 
LEVEL 2
 
LEVEL 3
 
COMMON STOCKS
 
Communication Services
 
$
364,552,189
   
$
364,552,189
   
$
   
$
 
Consumer Discretionary
   
627,437,858
     
593,044,278
     
30,776,816
     
3,616,764
 
Consumer Staples
   
24,836,567
     
24,836,567
     
     
 
Financials
   
76,513,307
     
76,513,307
     
     
 
Healthcare
   
243,615,860
     
243,615,860
     
     
 
Industrials
   
153,083,913
     
153,083,913
     
     
 
Information Technology
   
1,401,671,691
     
1,380,962,677
     
20,709,014
     
 
Materials
   
44,586,250
     
44,586,250
     
     
 
TOTAL COMMON STOCKS
 
$
2,936,297,635
   
$
2,881,195,041
   
$
51,485,830
   
$
3,616,764
 
REAL ESTATE INVESTMENT TRUST
 
Real Estate
   
6,563,460
     
6,563,460
     
     
 
SPECIAL PURPOSE VEHICLE
 
Information Technology
   
2,775,000
     
     
     
2,775,000
 
TOTAL INVESTMENTS IN SECURITIES
 
$
2,945,636,095
   
$
2,887,758,501
   
$
51,485,830
   
$
6,391,764
 
                                 
Alger 25 Fund
TOTAL
 
LEVEL 1
 
LEVEL 2
 
LEVEL 3
 
COMMON STOCKS
 
Communication Services
   
4,146,499
     
4,146,499
     
     
 
Consumer Discretionary
   
4,565,584
     
4,565,584
     
     
 
Financials
   
1,490,689
     
1,490,689
     
     
 
Healthcare
   
1,503,048
     
1,503,048
     
     
 
Industrials
   
556,600
     
556,600
     
     
 
Information Technology
   
11,243,887
     
11,243,887
     
     
 
Materials
   
593,564
     
593,564
     
     
 
TOTAL COMMON STOCKS
 
$
24,099,871
   
$
24,099,871
   
$
   
$
 
TOTAL INVESTMENTS IN SECURITIES
 
$
24,099,871
   
$
24,099,871
   
$
   
$
 

- 43 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


Alger 35 Fund
TOTAL
 
LEVEL 1
 
LEVEL 2
 
LEVEL 3
 
COMMON STOCKS
 
Communication Services
 
$
1,468,424
   
$
1,468,424
   
$
   
$
 
Consumer Discretionary
   
3,739,440
     
3,739,440
     
     
 
Consumer Staples
   
528,194
     
528,194
     
     
 
Financials
   
1,064,857
     
1,064,857
     
     
 
Healthcare
   
2,044,269
     
2,044,269
     
     
 
Industrials
   
1,423,681
     
1,423,681
     
     
 
Information Technology
   
5,572,012
     
5,572,012
     
     
 
TOTAL COMMON STOCKS
 
$
15,840,877
   
$
15,840,877
   
$
   
$
 
REAL ESTATE INVESTMENT TRUST
 
Real Estate
   
811,541
     
811,541
     
     
 
TOTAL INVESTMENTS IN SECURITIES
 
$
16,652,418
   
$
16,652,418
   
$
   
$
 
 
                               
Alger Growth & Income Fund
TOTAL
 
LEVEL 1
 
LEVEL 2
 
LEVEL 3
 
COMMON STOCKS
 
Communication Services
   
15,338,555
     
15,338,555
     
     
 
Consumer Discretionary
   
10,598,957
     
10,598,957
     
     
 
Consumer Staples
   
9,065,128
     
9,065,128
     
     
 
Energy
   
2,793,740
     
2,793,740
     
     
 
Financials
   
16,777,118
     
16,777,118
     
     
 
Healthcare
   
17,356,804
     
17,356,804
     
     
 
Industrials
   
7,739,662
     
7,739,662
     
     
 
Information Technology
   
34,334,424
     
34,334,424
     
     
 
Materials
   
1,979,391
     
1,979,391
     
     
 
Utilities
   
1,703,436
     
1,703,436
     
     
 
TOTAL COMMON STOCKS
 
$
117,687,215
   
$
117,687,215
   
$
   
$
 
MASTER LIMITED PARTNERSHIP
 
Energy
   
675,165
     
675,165
     
     
 
REAL ESTATE INVESTMENT TRUST
 
Financials
   
899,082
     
899,082
     
     
 
Real Estate
   
4,614,073
     
4,614,073
     
     
 
TOTAL REAL ESTATE INVESTMENT TRUST
 
$
5,513,155
   
$
5,513,155
   
$
   
$
 
SHORT—TERM INVESTMENTS
 
Money Market Fund
   
66,750
     
66,750
     
     
 
TOTAL INVESTMENTS IN SECURITIES
 
$
123,942,285
   
$
123,942,285
   
$
   
$
 
 
                               
Alger Mid Cap Growth Fund
TOTAL
 
LEVEL 1
 
LEVEL 2
 
LEVEL 3
 
COMMON STOCKS
 
Communication Services
   
18,847,995
     
18,847,995
     
     
 
Consumer Discretionary
   
47,076,733
     
43,343,567
     
3,733,166
     
 
Consumer Staples
   
3,347,912
     
3,347,912
     
     
 
Financials
   
9,442,862
     
9,442,862
     
     
 
Healthcare
   
61,242,611
     
61,242,611
     
     
 
Industrials
   
36,032,330
     
36,032,330
     
     
 
Information Technology
   
90,252,800
     
88,040,301
     
2,212,499
     
 
Materials
   
3,393,282
     
3,393,282
     
     
 
TOTAL COMMON STOCKS
 
$
269,636,525
   
$
263,690,860
   
$
5,945,665
   
$
 

- 44 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Alger Mid Cap Growth Fund
TOTAL
 
LEVEL 1
 
LEVEL 2
 
LEVEL 3
 
PREFERRED STOCKS
 
Healthcare
 
$
32,942
   
$
   
$
   
$
32,942
 
WARRANTS
 
Healthcare
   
4,502,418
     
     
4,502,418
     
 
RIGHTS
 
Healthcare
   
407,141
     
     
     
407,141
 
REAL ESTATE INVESTMENT TRUST
 
Real Estate
   
13,960,773
     
13,960,773
     
     
 
SPECIAL PURPOSE VEHICLE
 
Information Technology
   
1,675,000
     
     
     
1,675,000
 
TOTAL INVESTMENTS IN SECURITIES
 
$
290,214,799
   
$
277,651,633
   
$
10,448,083
   
$
2,115,083
 
 
                               
Alger Mid Cap Focus Fund
TOTAL
 
LEVEL 1
 
LEVEL 2
 
LEVEL 3
 
COMMON STOCKS
 
Communication Services
   
32,833,887
     
32,833,887
     
     
 
Consumer Discretionary
   
151,922,111
     
151,922,111
     
     
 
Financials
   
35,461,499
     
35,461,499
     
     
 
Healthcare
   
78,184,506
     
78,184,506
     
     
 
Industrials
   
91,287,873
     
91,287,873
     
     
 
Information Technology
   
175,733,299
     
175,733,299
     
     
 
Materials
   
6,065,480
     
6,065,480
     
     
 
TOTAL COMMON STOCKS
 
$
571,488,655
   
$
571,488,655
   
$
   
$
 
TOTAL INVESTMENTS IN SECURITIES
 
$
571,488,655
   
$
571,488,655
   
$
   
$
 
 
                               
Alger Weatherbie Specialized Growth Fund
TOTAL
 
LEVEL 1
 
LEVEL 2
 
LEVEL 3
 
COMMON STOCKS
 
Consumer Discretionary
   
177,815,024
     
177,815,024
     
     
 
Energy
   
40,207,138
     
40,207,138
     
     
 
Financials
   
192,368,734
     
192,368,734
     
     
 
Healthcare
   
432,108,241
     
432,108,241
     
     
 
Industrials
   
119,024,484
     
119,024,484
     
     
 
Information Technology
   
288,473,847
     
288,473,847
     
     
 
Real Estate
   
72,101,749
     
72,101,749
     
     
 
TOTAL COMMON STOCKS
 
$
1,322,099,217
   
$
1,322,099,217
   
$
   
$
 
PREFERRED STOCKS
 
Healthcare
   
34,721
     
     
     
34,721
 
TOTAL INVESTMENTS IN SECURITIES
 
$
1,322,133,938
   
$
1,322,099,217
   
$
   
$
34,721
 

- 45 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Alger Small Cap Growth Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
 
Communication Services
 
$
18,429,652
   
$
18,429,652
   
$
   
$
 
Consumer Discretionary
   
86,356,744
     
86,356,744
     
     
 
Consumer Staples
   
12,779,333
     
12,779,333
     
     
 
Energy
   
4,641,899
     
4,641,899
     
     
 
Financials
   
24,140,729
     
24,140,729
     
     
 
Healthcare
   
215,975,650
     
215,975,650
     
     
 
Industrials
   
21,514,682
     
21,514,682
     
     
 
Information Technology
   
139,968,234
     
139,968,234
     
     
 
Materials
   
4,513,776
     
4,513,776
     
     
 
TOTAL COMMON STOCKS
 
$
528,320,699
   
$
528,320,699
   
$
   
$
 
PREFERRED STOCKS
 
Healthcare
   
7,603
     
     
     
7,603
 
RIGHTS
 
Healthcare
   
120,600
     
     
     
120,600
 
REAL ESTATE INVESTMENT TRUST
 
Real Estate
   
6,528,420
     
6,528,420
     
     
 
SPECIAL PURPOSE VEHICLE
 
Information Technology
   
2,275,000
     
     
     
2,275,000
 
TOTAL INVESTMENTS IN SECURITIES
 
$
537,252,322
   
$
534,849,119
   
$
   
$
2,403,203
 
 
                               
Alger Small Cap Focus Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
 
Communication Services
   
100,930,918
     
100,930,918
     
     
 
Consumer Discretionary
   
729,845,271
     
729,845,271
     
     
 
Healthcare
   
4,006,637,629
     
4,006,637,629
     
     
 
Industrials
   
393,612,459
     
393,612,459
     
     
 
Information Technology
   
2,587,717,623
     
2,587,717,623
     
     
 
TOTAL COMMON STOCKS
 
$
7,818,743,900
   
$
7,818,743,900
   
$
   
$
 
RIGHTS
 
Healthcare
   
8,214
     
     
     
8,214
 
TOTAL INVESTMENTS IN SECURITIES
 
$
7,818,752,114
   
$
7,818,743,900
   
$
   
$
8,214
 
 
                               
Alger International Focus Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
 
Communication Services
   
11,264,342
     
     
11,264,342
     
 
Consumer Discretionary
   
42,170,856
     
11,858,359
     
30,312,497
     
 
Consumer Staples
   
4,578,517
     
     
4,578,517
     
 
Energy
   
3,317,835
     
     
3,317,835
     
 
Financials
   
27,481,391
     
10,509,963
     
16,971,428
     
 
Healthcare
   
15,042,836
     
3,411,197
     
11,631,639
     
 
Industrials
   
34,260,717
     
5,366,421
     
28,894,296
     
 
Information Technology
   
45,020,420
     
8,563,583
     
36,456,837
     
 
Materials
   
6,826,982
     
     
6,826,982
     
 
TOTAL COMMON STOCKS
 
$
189,963,896
   
$
39,709,523
   
$
150,254,373
   
$
 
TOTAL INVESTMENTS IN SECURITIES
 
$
189,963,896
   
$
39,709,523
   
$
150,254,373
   
$
 

- 46 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Alger Health Sciences Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
 
Financials
 
$
1,070,213
   
$
1,070,213
   
$
   
$
 
Healthcare
   
304,202,935
     
299,240,833
     
4,962,102
     
 
Information Technology
   
3,020,450
     
3,020,450
     
     
 
TOTAL COMMON STOCKS
 
$
308,293,598
   
$
303,331,496
   
$
4,962,102
   
$
 
PREFERRED STOCKS
 
Healthcare
   
134,605
     
     
     
134,605
 
WARRANTS
 
Healthcare
   
4,930,016
     
     
4,930,016
     
 
RIGHTS
 
Healthcare
   
1,350,327
     
     
     
1,350,327
 
TOTAL INVESTMENTS IN SECURITIES
 
$
314,708,546
   
$
303,331,496
   
$
9,892,118
   
$
1,484,932
 

 
FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Capital Appreciation Fund
Common Stocks
 
Opening balance at November 1, 2020
 
$
5,734,338
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(2,117,574
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at January 31, 2021
   
3,616,764
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at January 31, 2021
   
(2,117,574
)
         
Alger Capital Appreciation Fund
 
Special Purpose
Vehicle
 
Opening balance at November 1, 2020
 
$
2,775,000
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at January 31, 2021
   
2,775,000
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at January 31, 2021
   
 

- 47 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Mid Cap Growth Fund
Preferred Stocks
 
Opening balance at November 1, 2020
 
$
32,942
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at January 31, 2021
   
32,942
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at January 31, 2021
   
 
         
Alger Mid Cap Growth Fund
Rights
 
Opening balance at November 1, 2020
 
$
407,141
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at January 31, 2021
   
407,141
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at January 31, 2021
   
 
         
 
Alger Mid Cap Growth Fund
 
Special Purpose
Vehicle
 
Opening balance at November 1, 2020
 
$
1,200,000
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
475,000
 
Sales
   
 
Closing balance at January 31, 2021
   
1,675,000
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at January 31, 2021
   
 

- 48 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

   
FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Weatherbie Specialized Growth Fund
 
Preferred Stocks
 
Opening balance at November 1, 2020
 
$
34,721
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at January 31, 2021
   
34,721
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at January 31, 2021
   
 

   
FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3)
 
Alger Small Cap Growth Fund
 
Preferred Stocks
 
Opening balance at November 1, 2020
 
$
7,603
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at January 31, 2021
   
7,603
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at January 31, 2021
   
 

- 49 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

   
FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Small Cap Growth Fund
 
Rights
 
Opening balance at November 1, 2020
 
$
120,600
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at January 31, 2021
   
120,600
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at January 31, 2021
   
 
         
 
Alger Small Cap Growth Fund
 
Special Purpose
Vehicle
 
Opening balance at November 1, 2020
 
$
1,800,000
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
475,000
 
Sales
   
 
Closing balance at January 31, 2021
   
2,275,000
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at January 31, 2021
   
 

- 50 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

   
FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Small Cap Focus Fund
 
Rights
 
Opening balance at November 1, 2020
 
$
8,214
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at January 31, 2021
   
8,214
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at January 31, 2021
   
 

   
FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3)
 
Alger Health Sciences Fund
 
Preferred Stocks
 
Opening balance at November 1, 2020
 
$
134,605
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at January 31, 2021
   
134,605
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at January 31, 2021
   
 

- 51 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

   
FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Health Sciences Fund
 
Rights
 
Opening balance at November 1, 2020
 
$
1,350,327
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at January 31, 2021
   
1,350,327
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at January 31, 2021
   
 
 
The following table provides quantitative information about each Fund's Level 3 fair value measurements of the Funds' investments as of January 31, 2021. The table below is not intended to be all-inclusive, but rather provides information on the Level 3 inputs as they relate to the Funds' fair value measurements.
 

   
Fair Value
January 31, 2020
 
Valuation
Methodology
Unobservable
Input
 
Input/Range
   
Weighted
Average Inputs
 
Alger Capital Appreciation Fund
 
Common Stocks
   
3,616,764
 
Income Approach
Discount Rate
   
15.00%-50.00
%
   
N/A
 
Special Purpose Vehicle
   
2,775,000
 
Market Approach
Priced at Cost
   
N/A
     
N/A
 
Alger Mid Cap Growth Fund
 
Preferred Stocks
   
32,942
 
Income
Approach
Discount Rate
   
72.50%-77.50
%
   
N/A
 
Rights
   
407,141
 
Income Approach
Discount Rate
   
3.89%-4.77
%
   
N/A
 
Special Purpose Vehicle
   
1,675,000
 
Market Approach
Priced at Cost
   
N/A
     
N/A
 
Alger Weatherbie Specialized Growth Fund
 
Preferred Stocks
 
$
34,721
 
Income
Approach
Discount Rate
   
72.50%-77.50
%
   
N/A
 

- 52 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


   
Fair Value
January 31, 2021
 
Valuation
Methodology
Unobservable
Input
 
Input/Range
   
Weighted
Average Inputs
 
Alger Small Cap Growth Fund
 
Preferred Stocks
   
7,603
 
Income Approach
Discount Rate
   
72.50%-77.50
%
   
N/A
 
Rights
   
120,600
 
Income Approach
Discount Rate
   
3.89%-4.77
%
   
N/A
 
Special Purpose Vehicle
   
2,275,000
 
Market Approach
Priced at Cost
   
N/A
     
N/A
 
Alger Small Cap Focus Fund
 
Rights
 
$
8,214
 
Income Approach
Discount Rate
   
3.89%-4.77
%
   
N/A
 
Alger Health Sciences Fund
 
Preferred Stocks
   
134,605
 
Income Approach
Discount Rate
   
72.50%-77.50
%
   
N/A
 
Rights
   
1,350,327
 
Income Approach
Discount Rate
   
3.89%-4.77
%
   
N/A
 
 
The significant unobservable inputs used in the fair value measurement of the Fund's securities are revenue and EBITDA multiples, discount rates, and the probabilities of success of certain outcomes. Significant increases and decreases in these inputs in isolation and interrelationships between these inputs would have resulted in significantly higher or lower fair value measurements than those noted in the table above. Generally, all other things being equal, increases in revenue and EBITDA multiples, decreases in discount rates, and increases in the probabilities of success result in higher fair value measurements, whereas decreases in revenues and EBITDA multiples, increases in discount rates, and decreases in the probabilities of success result in lower fair value measurements.
 
Certain of the Funds’ assets and liabilities are held at carrying amount or face value, which approximates fair value for financial statements purposes. As of January 31, 2021, such assets were categorized within the ASC 820 disclosure hierarchy as follows:
 
   
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
Cash, Foreign Cash and Cash Equivalents:
 
Alger Capital Appreciation Fund
 
$
26,443,870
   
$
   
$
26,443,870
   
$
 
Alger 25 Fund
   
23,145
     
     
23,145
     
 
Alger 35 Fund
   
689,770
     
     
689,770
     
 
Alger Growth & Income Fund
   
1,124,132
     
     
1,124,132
     
 
Collateral on securities loaned
   
66,750
     
     
66,750
     
 
Alger Mid Cap Growth Fund
   
2,805,710
     
     
2,805,710
     
 
Alger Mid Cap Focus Fund
   
5,284,256
     
     
5,284,256
     
 
Alger Weatherbie Specialized Growth Fund
   
36,214,548
     
     
36,214,548
     
 
Alger Small Cap Growth Fund
   
50,433,487
     
     
50,433,487
     
 
Alger Small Cap Focus Fund
   
222,892,625
     
     
222,892,625
     
 
Alger International Focus Fund
   
11,087,506
     
3,153,538
     
7,933,968
     
 
Alger Health Sciences Fund
   
1,311,489
     
     
1,311,489
     
 

- 53 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

NOTE 4 — Derivatives:
 
FASB Accounting Standards Codification 815 – Derivatives and Hedging (“ASC 815”) requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.
 
Options—The Funds seek to capture the majority of the returns associated with equity market investments. To meet this investment goal, the Funds invest in a broadly diversified portfolio of common stocks, the Funds may also buy and sell call and put options on equities and equity indexes. The Funds may also purchase call options to increase their exposure to the stock market and also provide diversification of risk. The Funds may also purchase put options in order to protect from significant market declines that may occur over a short period of time. The Funds may also write covered call and cash secured put options to generate cash flows while reducing the volatility of the Funds’ portfolios. The cash flows may be an important source of the Funds’ returns, although written call options may reduce the Funds’ ability to profit from increases in the value of the underlying security or equity portfolio. The value of a call option generally increases as the price of the underlying stock increases and decreases as the stock decreases in price. Conversely, the value of a put option generally increases as the price of the underlying stock decreases and decreases as the stock increases in price. The combination of the diversified stock portfolio and the purchase and sale of options is intended to provide the Funds with the majority of the returns associated with equity market investments but with reduced volatility and returns that are augmented with the cash flows from the sale of options.
 
The Funds’ option contracts were not subject to any rights of offset with any counterparty. All of the Funds’ options were exchange traded which utilize a clearinghouse that acts as an intermediary between buyer and seller, receiving initial and maintenance margin from both, and guaranteeing performance of the option contract.
 
Forward Foreign Currency Contracts—In connection with portfolio purchases and sales of securities denominated in foreign currencies, the Funds may enter into forward foreign currency contracts. Additionally, each Fund may enter into such contracts to economically hedge certain other foreign currency denominated investments. These contracts are valued at the current cost of covering or offsetting such contracts and the related realized and unrealized foreign exchange gains and losses are included in the Statements of Operations. In the event that counterparties fail to settle these currency contracts or the related foreign security trades, a Fund could be exposed to foreign currency fluctuations.
 
There were no derivative instruments held by the Funds throughout the period or as of January 31, 2021.
 
NOTE 5 — Affiliated Securities:

 
The issuers of the securities listed below are deemed to be affiliates of the Funds because the Funds or their affiliates owned 5% or more of the issuer’s voting securities during all or part of the period ended January 31, 2021. Information regarding the Funds’ holdings of such securities is set forth in the following table:
 
- 54 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
 
 
Security
 
Value at
October 31,
2020
   
Purchases/
Conversion
   
Sales/
Conversion
   
Dividend/
Interest
Income
   
Realized
Gain (Loss)
   
Net Change
in
Unrealized
App(Dep)
   
Value at
January 31,
2021
 
Alger Capital Appreciation Fund
 
Special Purpose Vehicle
                                         
Crosslink Ventures Capital LLC, Cl. A
 
$
2,775,000
   
$
   
$
   
$
   
$
   
$
   
$
2,775,000
 
Total
 
$
2,775,000
   
$
   
$
   
$
   
$
   
$
   
$
2,775,000
 

 
Security
 
Value at
October 31,
2020
   
Purchases/
Conversion
   
Sales/
Conversion
   
Dividend/
Interest
Income
   
Realized
Gain (Loss)
   
Net Change
in
Unrealized
App(Dep)
   
Value at
January 31,
2021
 
Alger Mid Cap Growth Fund
                                         
Preferred Stocks
                                         
Prosetta Biosciences, Inc., Series D
 
$
32,942
   
$
   
$
   
$
   
$
   
$
   
$
32,942
 
Special Purpose Vehicle
                                                       
Crosslink Ventures Capital LLC, Cl. A
   
1,200,000
     
     
     
     
     
     
1,200,000
 
Crosslink Ventures Capital LLC, Cl. B
   
     
475,000
     
     
     
     
     
475,000
 
Total
 
$
1,232,942
   
$
475,000
   
$
   
$
   
$
   
$
   
$
1,707,942
 

 
Security
 
Value at
October 31,
2020
   
Purchases/
Conversion
   
Sales/
Conversion
   
Dividend/
Interest
Income
   
Realized
Gain (Loss)
 
Net Change
in
Unrealized
App(Dep)
   
Value at
January 31,
2021
 
Alger Weatherbie Specialized Growth Fund
 
Preferred Stocks
                                         
Prosetta Biosciences, Inc., Series D
 
$
34,721
   
$
   
$
   
$
   
$
   
$
   
$
34,721
 
Total
 
$
34,721
   
$
   
$
   
$
   
$
   
$
   
$
34,721
 

 
Security
 
Value at
October 31,
2020
   
Purchases/
Conversion
   
Sales/
Conversion
   
Dividend/
Interest
Income
   
Realized
Gain (Loss)
   
Net Change
in
Unrealized
App(Dep)
   
Value at
January 31,
2021
 
Alger Small Cap Growth Fund
                                         
Preferred Stocks
                                         
Prosetta Biosciences, Inc., Series D
 
$
7,603
   
$
   
$
   
$
   
$
   
$
   
$
7,603
 
Special Purpose Vehicle
                                                       
Crosslink Ventures Capital LLC, Cl. A
   
1,800,000
     
     
     
     
     
   
$
1,800,000
 
Crosslink Ventures Capital LLC, Cl. B
   
     
475,000
     
     
     
     
   
$
475,000
 
Total
 
$
1,807,603
   
$
475,000
   
$
   
$
   
$
   
$
   
$
2,282,603
 

- 55 -

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
Security
Value at
October 31,
2020
 
Purchases/
Conversion
 
Sales/
Conversion
 
Dividend/
Interest
Income
 
Realized
Gain (Loss)
 
Net Change
in
Unrealized
App(Dep)
 
Value at
January 31,
2021
 
Alger Health Sciences Fund
                           
Preferred Stocks
                           
Prosetta Biosciences, Inc., Series D
 
$
134,605
   
$
   
$
   
$
   
$
   
$
   
$
134,605
 
Total
 
$
134,605
   
$
   
$
   
$
   
$
   
$
   
$
134,605
 


- 56 -